An in vivo RNAi approach to study gene function in hematopoiesis by Tazreiter, Marie-Theres
DIPLOMARBEIT
An in vivo RNAi Approach to study Gene
Function in Hematopoiesis
Verfasserin
Marie-Theres Tazreiter
angestrebter akademischer Grad
Magistra der Naturwissenschaften (Mag. rer. nat.)
Wien, 2011
Studienkennzahl A490
Studienrichtung Diplomstudium Molekulare Biologie
Betreuer Prof. Dr. Josef M. Penninger
2
Abstract
Hematopoiesis is a developmental process in which hematopoietic stem cells give
rise to a variety of blood cell types with diﬀerent morphologies and diverse func-
tions [Tavian et al., 2010]. The hematopoietic compartment is a highly dynamic
system composed of relatively short-lived cells of which millions are newly gener-
ated by the bone marrow every day and thus needs to be tightly regulated by a
fine balance between proliferation, diﬀerentiation and apoptosis [Dingli and Pacheco,
2010]. Consequently, deregulation of hematopoietic diﬀerentiation or homeostasis
builds the basis for various hematopoietic disorders such as lymphomas, leukemias or
autoimmune diseases [Kondo et al., 2003].
Using blood cell-specific RNAi silencing in Drosophila larvae, a screen of evolu-
tionarily conserved genes for hematopoiesis identified 356 genes implicated in blood
cell homeostasis in the fly [Elling et al., unpublished]. The genes causing the
strongest phenotypes, namely “fly leukemia” characterized by marked overprolifer-
ation of macrophage-like plasmatocytes and formation of melanotic tumors, included
amongst others the protease inhibitor Papilin, two transcriptional co-regulators called
Symplekin and Ssrp1 as well as several genes involved in the regulation of endocyto-
sis: the small GTPase Rab5a, the SNARE protein Stx7 and the two HOPS/CORVET
complex subunits Vps16 and Vps33a. In order to characterize the relevance of these
identified factors in the mammalian hematopoietic system in vivo, we applied a bone
marrow chimeric approach to test the hematopoietic potential of bone marrow cells
with down-regulated expression of either of these genes.
The knock-down of three of the analyzed genes, namely Symplekin, Rab5a and
Vps16, resulted in an increase of either mature or immature myeloid cells in lethally-
irradiated recipient mice, while promoting a decreased percentage of lymphoid B- or
T-cells, indicating an impairment of lineage decision in favor of the myeloid lineage.
Moreover, the down-regulation of the same genes in bone marrow cells was associated
with an elevated percentage of innate natural killer cells in the spleens of transplanted
mice. Analysis of the hematopoietic compartment of Papilin mutant mice revealed
that these mice harbor decreased numbers of granulocytes in the peripheral blood
which correlated with a significant reduction in the percentage of c-kit+ myeloid
precursor cells in the bone marrow. These data indicate that the conserved factors
identified to regulate proliferation and homeostasis of blood cells in the fruit fly
Drosophila melanogaster directly translate into conserved mammalian genes involved
in hematopoiesis.
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Zusammenfassung
Hämatopoiese beschreibt den entwicklungbiologischen Vorgang der Diﬀerenzierung
hämatopoetischer Stammzellen zu den verschiedenen Blutzellytpen [Tavian et al.,
2010]. Aufgrund der Kurzlebigkeit von Blutzellen, müssen täglich mehrere Millionen
Blutzellen neu vom Knochenmark gebildet werden. Dieser hohe “Turnover” erfordert
ein stetiges Gleichgewicht zwischen den Prozessen Wachstum, Diﬀerenzierung und
Zelltod, um die Homöostase des dynamischen Blutsystems zu garantieren [Dingli
and Pacheco, 2010]. Eine Störung dieses Gleichgewichts kann verschiedene häma-
tologische Erkrankungen wie Lymphome, Leukämien oder Autoimmunerkrankungen
zur Folge haben [Kondo et al., 2003].
Anhand eines blut-spezifischen, RNAi-basierenden Screens in der Drosophila Larve
wurden 356 konservierte Gene identifiziert, die an der Regulation der Blutbildung
in der Fruchtfliege beteiligt sind [Elling et al., unveröﬀentlicht]. Die fehlende Ex-
pression einiger dieser Gene in den Blutzellen der Larve führte zur Entstehung einer
sogenannten “Fliegenleukämie”, die sich durch eine stark vermehrte Bildung von
Makrophagen-ähnlichen Plasmatozyten und das Auftreten von stark pigmentierten
Tumoren, sogenannten “melanotic tumors”, auszeichnet. Zu den Genen, die zu einem
besonders starken Phänotyp in der Fliege führten, zählen der Proteaseinhibitor Pa-
pilin, zwei transkritionelle Koregulatoren namens Symplekin und Ssrp1, und mehrere
Faktoren, die an der Regulation der Endozytose beteiligt sind, nämlich die kleine GT-
Pase Rab5a, das SNARE Protein Syntaxin 7 sowie zwei Untereinheiten des HOPS/
CORVET-Komplexes namens Vps16 und Vps33a. Durch die Analyse von Knochen-
markchimären, haben wir getestet, ob die genannten Gene auch bei der Blutbildung
in Säugetieren eine Rolle spielen. In unseren Versuchen wurde die Expression des
jeweils zu untersuchenden Gens in Vorläuferzellen aus dem Knochenmark hinunter-
reguliert. Anschließend wurde die Fähigkeit dieser Vorläuferzellen in die verschiedenen
Blutzelllinien zu diﬀerenzieren durch deren Transplantation in Mäuse getestet.
Vorläuferzellen, die eine verminderte Expression von entweder Symplekin, Rab5a
oder Vps16 aufwiesen, entwickelten sich bevorzugt zu reifen oder unreifen myeloiden
Blutzellen, während diese Vorläuferzellen seltener zu B- oder T-Lymphozyten diﬀeren-
zierten. Dies ist ein Hinweis darauf, dass die sogenannte “lineage decision” beein-
trächtigt sein könnte. Außerdem förderte die Herabregulation der selben Gene eine
vermehrte Bildung von natürlichen Killerzellen in der Milz der Rezipienten. Weiters
konnten wir zeigen, dass die Granulozytenpopulation im peripheren Blut von Papilin
Knockout-Mäusen vermindert ist. Dieser Befund korrelierte mit einem niedrigeren
Prozentsatz von myeloiden Vorläuferzellen im Knochenmark dieser Mäuse im Ver-
gleich zu Wildtyp-Mäusen. Unsere Resultate deuten darauf hin, dass die konservierten
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Gene, die ursprünglich als Regulatoren für die Blutbildung und Homöostase in Frucht-
fliegen identifiziert wurden, auch eine Role in der Regulation der Hämatopoiese in
Säugetieren spielen.
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1 Introduction
1.1 The fruit fly Drosophila melanogaster as model
organism to study hematopoiesis
In the last decade, the fruit fly Drosophila melanogaster has become a powerful
tool to study basic molecular mechanisms. First, the full genomic sequence of the
fly genome was resolved in the year 2000 [Adams et al., 2000], revealing that more
than half of the Drosophila proteins share similarities with mammalian proteins [Ru-
bin et al., 2000]. Moreover, it was shown that not only proteins involved in core
biological processes, such as metabolism, transport and cell structure are conserved
among insects and vertebrates [Lopez-Bigas et al., 2008], but Drosophila orthologs
have also been identified for more than 60% of genes implicated in a diverse set of
human disease [Fortini et al., 2000]. On the other hand, the discovery of new potent
techniques such as targeted gene knock-down by RNA interference [Fire et al., 1998]
and the generation of stable transgenic RNAi lines, enabling tissue- and time-specific
knock-down of individual genes [Kennerdell and Carthew, 2000], paved the way for
the model organism Drosophila to become a strong and reliable genetic tool to study
conserved gene function.
Interestingly, despite the phylogenetic distance of arthropods and vertebrates of
about 964 million years [Hedges et al., 2004], the development of the hematopoi-
etic system in Drosophila melanogaster and mammals displays an eminent functional
similarity [Evans et al., 2003]. Analogous to vertebrates, hematopoiesis in the de-
veloping fly can be divided into two spatially and temporally distinct phases. The
first wave of hematopoiesis occurs in the early embryo, when blood cell progeni-
tors, so called prohemocytes, diﬀerentiate from the head mesoderm and populate
the embryo [Tepass et al., 1994]. During the second hematopoietic phase, hemo-
cytes are derived from a specialized mesodermal organ, the so called lymph gland,
that only exists during the larval stages of development [Shrestha and Gateﬀ, 1982].
Upon the onset of metamorphosis, the lymph gland degenerates and diﬀerentiated
hemocytes are released into the hemolymph. These two hemocyte populations, orig-
inating from the embryonic and the larval stage, persist throughout metamorphosis
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and form the cellular components of the blood in the adult fly [Holz et al., 2003].
Although the existence of hematopoietic stem cells in the Drosophila lymph gland has
been demonstrated by lineage tracing experiments [Minakhina and Steward, 2010],
to date no evidence for an imaginal organ harboring hematopoietic stem cells in
adult fly equivalent to the bone marrow in mammals has been identified [Holz et al.,
2003; Krzemien et al., 2010]. Analogously, the hematopoietic precursors in verte-
brates are generated at two distinct times and locations in the embryo [Dzierzak
and Speck, 2008]: Primitive hematopoiesis occurring in the extra-embryonic yolk sac
gives rise to the first blood cell progenitors, which are basically of erythroid nature
[Godin and Cumano, 2002]. Definitive hematopoiesis in the mesodermal aorta/gonad/
mesonephros (AGM) region provides the long-lived hematopoietic stem cells, which
subsequently seed the fetal liver and the bone marrow and generate the mature blood
cell lineages of the mammalian immune system [Medvinsky et al., 2011].
Due to the phylogenetic distance between arthropods and vertebrates, the blood
cell types in the fly are less diverse and primarily comprise the innate branch of
immunity [Evans et al., 2003]. Notably, the tracheal system maintains the oxygen
supply in insects and thus no erythroid lineage exists. Furthermore, no cell type that
is equivalent to the lymphoid lineage can be found in Drosophila [Williams, 2007].
Subsequently, prohemocytes develop into cells that closely resemble the mammalian
myeloid lineage and can be classified into three terminally diﬀerentiated types: plas-
matocytes, crystal cells and lamellocytes (Figure1.1) [Meister, 2004]. Plasmatocytes
function as phagocytic cells, that constitute 90-95% of all blood cells in the fly and
share several similarities with vertebrate macrophages or monocytes. During de-
velopment these cells play a critical role in morphogenesis by eliminating apoptotic
cells and secreting and remodeling the extracellular matrix [Lanot et al., 2001], while
in the course of an immune response plasmatocytes are responsible for phagocyto-
sis of invading bacteria or fungi [Lemaitre and Hoﬀmann, 2007]. Additionally, these
macrophage-like cells stimulate the humoral immune response by secreting antimicro-
bial peptides [Dimarcq et al., 1997] and cytokine-like molecules [Agaisse et al., 2003].
The other two cell types, namely crystal cells and lamellocytes, do not have known ho-
mologs in mammals. Crystal cells, the second most abundant blood cell population,
functions in innate immune responses as well as wound healing processes. This cell
type is characterized by crystalline inclusions storing large amounts of prophenoloxi-
dase [Rizki et al., 1980; Waltzer et al., 2002] that catalyzes the humoral production
of melanin, which in turn, together with its biosynthetic byproducts, is cytotoxic to
pathogens [Reumer et al., 2010]. The third hemocyte lineage is presented by the
lamellocytes, which are large, flat and adherent cells nearly absent in normal larvae.
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Upon parasitisation diﬀerentiation of these immune cells is massively induced, which
then function in the encapsulation and neutralisation of invading parasites too large
to be phagocytosed by plasmatocytes [Meister, 2004].
Importantly, several transcription factors and signaling pathways controlling hemato-
poiesis are highly conserved between Drosophila and vertebrates [Evans et al., 2007]
(Figure 1.1). For instance, the transcription factor Serpent (Srp) that was identi-
fied as central determinant of hemocyte fate, belongs to the conserved GATA family
of zinc finger transcription factors [Rehorn et al., 1996]. Similarly, the orthologous
factors GATA-1, GATA-2 and GATA-3 in the mouse have fundamental roles in cell
fate determination and hematopoietic development [Bresnick et al., 2010]. More-
over, Srp interacts with two other conserved factors, namely U-shaped (Ush) and
Lozenge (Lz), to further control hemocyte diﬀerentiation [Fossett et al., 2003]. The
friend-of-GATA (FOG) homolog Ush acts together with Srp to repress crystal cell fate
[Fossett et al., 2003], whereas in the mouse, FOG-1 regulates together with GATA-1
erythropoiesis and megakaryopoiesis [Tsang et al., 1997]. On the other hand, Srp
works in concert with Lz to promote crystal cell diﬀerentiation [Fossett et al., 2003].
Lz shares significant similarities with human AML-1/Runx1 [Daga et al., 1996], which
also interacts with GATA-1 in the mouse [Elagib et al., 2003] and is often mutated
in acute myeloid leukemia (AML) [Renneville et al., 2008]. The factors that confer
plasmatocyte lineage diﬀerentiation and block crystal cell development are known
as Glial-cell-missing (Gcm and Gcm2) proteins [Alfonso and Jones, 2002]. Although
there are two homologous Gcm proteins found in mammals, no known hematopoi-
etic function has yet been identified, though they have been indicated in controlling
diﬀerentiation of the placenta, thymus, and kidney [Hartenstein, 2006].
Functional similarity among flies and vertebrates can be seen also in regard to the
hematopoietic microenvironment. The larval lymph gland harbors a signaling cell
population in the so-called posterior signaling center (PSC) controlling blood cell
diﬀerentiation [Lebestky et al., 2003]. This signaling cells functionally resemble the
stromal cells in mammalian bone marrow. Moreover, the most important conserved
signal transduction pathways regulating hematopoietic development include for in-
stance the Notch pathway, which plays a critical role in lineage specification and crys-
tal cell development [Lebestky et al., 2003]. Interestingly, not only cells of the PSC
express the Notch ligand Serrate (Ser), its murine homolog Jagged-1 is also present
on stromal cells in the bone marrow in mice [Lindsell et al., 1995]. Furthermore, the
generation of hematopoietic stem cells (HSCs) from endothelial cells and the diﬀer-
entiation of the myeloid lineage in mammals is controlled by Notch-1 [Kumano et al.,
2001, 2003]. Another conserved signaling route through the PDGF/VEGF receptor,
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Figure 1.1: Hematopoiesis in mice (A) and Drosophila (B). Conserved proteins and
pathways regulating hematopoiesis are highlighted in green and red. Scheme was
adapted from Evans et al., 2003. Abbreviations: Erythrocyte/Megakaryocyte pre-
cursor (EM precursor); Granulocyte/Monocyte/Macrophage precursor (GM precur-
sor); Serpent (Srp); Lozenge (Lz); U-shaped (Ush); Glial-cell-missing (Gcm/Gcm2);
Notch (N); Hopscotch (Hop); Toll (Tl).
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known as PVR in Drosophila, mediates hemocyte survival and migration in the fly
[Cho et al., 2002], whereas it promotes B cell development and inhibits dendritic cell
maturation in vertebrates [Hattori et al., 2001; Gabrilovich et al., 1996]. Moreover,
increased expression of either receptor or ligand of the PDGF pathway is associated
with various hematologic malignancies [Gerber and Ferrara, 2003; Birk et al., 2008].
Additionally, JAK/STAT signaling, known to be involved in hematopoietic develop-
ment in mammals, also modulates hemocyte proliferation and diﬀerentiation [Hou
et al., 2002]. As a final example, the Toll pathway was identified to control hemocyte
proliferation by activating the NF-κB homolog Relish [Qiu et al., 1998]. Although the
Toll pathway primarily mediates innate immune responses in vertebrates [Barton and
Kagan, 2009; Silverman and Maniatis, 2001], dysfunction of factors downstream of
the Toll-like receptor, such as NFκB or its inhibitor IκB, is related to several cancers
including leukemias and lymphomas [Wong and Tergaonkar, 2009].
In summary, numerous functional and molecular processes directing hematopoiesis
are conserved between Drosophila melanogaster and mammals. This strengthens the
idea of identifying novel regulators of blood cell formation and homeostasis in the
fly, which might highlight yet unknown orthologous players and mechanisms in mice
and even humans. Importantly, several recent genome-wide screens in Drosophila
melanogaster were successful in identifying novel conserved genes involved in obesity,
pain sensitivity as well as regulation of heart function [Pospisilik et al., 2010; Neely
et al., 2010a,b], confirming the fruit fly as a useful model organism for such studies.
1.2 An in vivo high-throughput screen to identify
novel regulators of hematopoiesis in Drosophila
melanogaster
In order to identify conserved genes required for blood cell formation and homeostasis,
a blood cell specific RNA interference (RNAi) screen was conducted in the fly [Elling
et al., unpublished]. For conditional knock-down of the selected target genes, 8800
diﬀerent lines of the Vienna global Drosophila RNAi library [Dietzl et al., 2007] were
crossed to the hemocyte specific hemolectin-GAL4 (hml-GAL4) driver line, which
expresses the transcriptional activator GAL4 in the lymph gland as well as in circu-
lating plasmatocytes and crystal cells throughout all larval stages [Goto et al., 2003].
GAL4 subsequently induces gene silencing by dsRNA expression controlled by the
UAS promoter. The resultant progeny of the first generation was then screened for
increased or decreased numbers of plasmatocytes or crystal cells and for the presence
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of melanotic tumors or giant cells in third instar (L3) larvae. Plasmatocytes were
visualised by using the UAS-GFP reporter line, while crystal cells could be detected
as black dots after heating the larvae to 60°C for 10 minutes [Duvic et al., 2002].
The primary screen identified 620 lines that were positive for one or more of the
above stated phenotypes. Retesting of these primary hits reduced the number to a
total set of 356 genes (Figure 1.2).
Figure 1.2: Schematic for genome-wide RNAi Screen for regulators of hematopoiesis
in Drosophila larvae. Virgin Hml-Gal4 females were crossed to UAS-RNAi transgenic
males and the cell number of plasmatocytes and crystal cells in late L3 larvae of the
F1 progeny was determined. A total of 8800 lines were screened, identifying 620 lines
as primary hits. The secondary screen confirmed 420 hits, representing 356 genes.
Amongst the identified candidates, the majority of genes caused general cell loss
upon deficiency, whereas only a small number of the hits led to marked overprolifera-
tion of hemocytes. The overrepresentation of the phenotype of decreased hemocyte
numbers might be due to the fact that many of the identified genes encode ribo-
somal proteins or factors involved in oxidative phosphorylation or other core house-
keeping functions, which are essential for cell survival. Importantly, known regulators
of blood cell development and homeostasis, such as Notch and its ligand Serrate,
VEGF/PDGF Receptor (PVR), U-shaped or lesswright, were identified, thereby val-
idating the screening strategy. The identified genes were categorized according to
their assigned function by cluster analysis, revealing that more than 100 of the 356
identified genes are novel and do not connect to any cluster. Moreover, these genes
do not have any assigned function in hematopoiesis. The large interaction networks
mainly group genes mediating housekeeping functions such as ribosomal proteins or
cell cycle regulators. Figure 1.3 shows a cluster analysis of all genes causing overpro-
liferation of plasmatocytes. Furthermore, genes additionally causing increase of the
crystal cell compartment and melanotic tumor formation are marked. Interestingly,
14
gene ontology (GO) term analysis showed a significant enrichment of a small group
of genes involved in endocytosis which are highlighted in the cluster analysis (genes
in red circle; Figure 1.3).
To select promising candidates for further validation in a mammalian model system,
we focused on the small set of genes causing overproliferation of plasmatocytes mainly
for two reasons. First, plasmatocytes are the only hemocyte type showing functional
similarities to a mammalian blood cell type, namely macrophages or monocytes,
respectively. Second, we reasoned that it would be technically easier to model an
increase in cell number than to look for the decrease of any blood cell type, since
the expression of the candidate genes is more or less abundant in all mammalian
hematopoietic lineages, not solely in the plasmatocyte-like macrophages. Primarily
based on a high score in the screen, the expression of the gene in the murine blood
system and hematopoietic tissues and the assigned molecular function, we selected
the following candidates for the follow-up study in mice: Papilin (Ppn), Structure
specific recognition protein 1 (Ssrp1), Symplekin (Sympk), and four genes involved
in endocytosis, namely the Ras-related protein Rab5a, Syntaxin 7 (Stx7) and the two
vacuolar protein sorting proteins Vps16 and Vps33a, which are highlighted in blue in
the cluster analysis (Figure 1.3).
1.3 Candidate genes
1.3.1 Structure specific recognition protein 1
The murine Structure specific recognition protein 1 (Ssrp1) is highly conserved to its
fruit fly homolog with 49% identity in the amino acid sequence (http://www.ebi.ac.uk
/Tools/sss/ncbiblast). In mice, the factor is also known as T160 and was first isolated
in a screen for DNA-binding components of a putative V-(D)-J-recombinase from a
mouse pro-B cell line [Shirakata et al., 1991]. The protein was identified to bind
to DNA containing recombination signal sequences (RSS) with its carboxy terminal
high-mobility group (HMG) homology region. However, recombinase activity has not
been demonstrated so far. Independently, the human homolog, SSRP1, was found
to interact specifically with DNA modified by cis-diamminedichloroplatinum(II) (cis-
DDP or cisplatin) and consequently it was suggested to be involved in DNA repair
[Toney et al., 1989]. Further characterization of murine Ssrp1 revealed that the
protein is highly expressed in tissues containing fast proliferating cells including the
spleen, thymus, lymph nodes, bone marrow, testis and the ovary. Additionally, it
was shown that Ssrp1 colocalizes with replication foci in the nucleus of mid to late
15
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Figure 1.3: Cluster analysis of all genes associated with plasmatocyte overprolifer-
ation. Potential interactions between genes were visualized using Cytoscape. Nodes
represent individual genes and lines represent putative associations. Round nodes
represent all genes causing plasmatocyte overproliferation. Genes causing additional
phenotypes such as increased number of crystal cells or induction of melanotic tumors
are indicated by squares nodes or thicker border lines, respectively. Genes highlighted
in red mark already known regulators of hematopoiesis in Drosophila, while blue high-
lighted genes were selected for validation in mice. The red circle distinguishes genes
with the GO term endocytosis. Interaction data were derived from DroID, STRING
and BioGRID, and include direct experimental interaction evidence from D. mel. as
well as genetic and interolog links, text mining and pathway based association.
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S phase cells, suggesting a role in cellular DNA replication [Hertel et al., 1999].
At the same time, human SSRP1 was identified to form a heterodimer with p140/
hSpt16, the human homolog of the yeast Spt16/Cdc68 [Orphanides et al., 1999].
This complex, known as the FACT complex (facilitates chromatin transaction) is in-
volved in a wide range of cellular processes, including initiation of transcription, tran-
scriptional elongation, DNA replication as well as DNA repair [Formosa, 2008]. Dur-
ing transcription, binding of the FACT complex to the nucleosome leads to destabi-
lization of the histone octamere, triggering the delocalization of one H2A/H2B dimer
upon Pol-II passage and thereby facilitates elongation
[Belotserkovskaya and Reinberg, 2004]. Additionally, FACT harbors a histone chap-
eron activity and is able to mediate histone core deposition onto DNA
[Belotserkovskaya et al., 2003]. The ability of FACT to overcome nucleosomal barri-
ers [Jimeno-Gonzalez et al., 2006], as well as its capability to enhance binding of the
TATA binding protein to a TATA site in a nucleosome [Biswas et al., 2004], plays an
important role in transcription initiation. During DNA replication, FACT is recruited
to replication origins by the replicative helicase complex (MCM), where it promotes
initiation of DNA synthesis and progression of the MCM helicase [Tan et al., 2006].
Several lines of evidence implicate Ssrp1 in DNA damage repair: Upon UV irradia-
tion, FACT forms a complex with casein kinase 2 (CK2), causing the selective phos-
phorylation of p53 at Ser-392 and thereby enhancing its activity [Keller et al., 2001;
Keller and Lu, 2002]. Interestingly, Ssrp1 appears to have functions independent of
Spt16 as well: It was shown that mammalian Ssrp1 functions as a transcriptional co-
regulator by directly interacting with other activators of transcription such as serum
response factor (SRF) or the p53 homolog p63 [Spencer et al., 1999; Zeng et al.,
2002a]. More recently, gene expression profiling after siRNA mediated knock-down of
Ssrp1 or Spt16 revealed that the expression of a subset of genes is regulated by Ssrp1,
independent of Spt16 [Li et al., 2007]. In light of the diverse cellular functions of
Ssrp1, it is not surprising that the targeted disruption of Ssrp1 in the mouse results in
early embryonic lethality soon after implantation [Cao et al., 2003]. Taken together,
the intriguing expression profile of Ssrp1, especially in hematopoietic tissue, as well
as its function as a transcriptional co-regulator, suggested that the factor might be
a suitable candidate for addressing its role in hematopoiesis.
1.3.2 Symplekin
Symplekin derives its name from the Greek word ’σ￿υ￿πλέκειν’, which stands for “to
tie together”, because it was initially found to be associated with the cytoplasmic
plaque domain of tight junctions in the zonula occludens of polarized epithelial cells
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in humans [Keon et al., 1996]. Interestingly, Symplekin was also shown to local-
ize primarily to the nucleoplasm in cells that do not form tight junctions, such as
fibroblasts, endothelial cells and most importantly lymphocytes in the lymph node
[Keon et al., 1996]. Functionally, Symplekin acts as a scaﬀold in a large protein com-
plex that is required for 3’-end cleavage and polyadenylation of eukaryotic messenger
RNA precursors [Takagaki and Manley, 2000]. Additionally, Symplekin was identi-
fied to be essential for cytoplasmic polyadenylation as well as maturation of histone
mRNAs, which are not polyadenylated [Barnard et al., 2004; Kolev and Steitz, 2005].
Moreover, Symplekin is implicated in the modulation of gene expression by two mech-
anisms: First, the polyadenylation machinery interacts with the preinitiation complex
at the promoter as well as with the C-terminal domain (CTD) of the RNA polymerase
II itself, thereby coupling RNA processing to transcription initiation, elongation as
well as termination [Calvo and Manley, 2003]. On the other hand, Symplekin has
been shown to directly interact with the transcription factor heat shock factor 1
(HSF1) in a stress-dependent manner, thereby inducing the transcription of stress
response genes [Xing et al., 2004]. Moreover, the tight junction protein cooperates
with the Y-box transcription factor ZONAB/DbpA in regulating the expression of
Cyclin D1, thereby promoting proliferation of epithelial cells [Kavanagh et al., 2006].
Finally, the finding that the Symplekin/ZONAB complex represses the expression of
AML-1/Runx1, a gene often mutated in human leukemias [Buchert et al., 2009],
prompted us to validate its function in the hematopoietic system in mice.
1.3.3 Candidates involved in endocytosis: Rab5a, Syntaxin 7,
Vps16 and Vps33a
Endocytosis is the regulated process by which cells internalize macromolecules from
the environment into transport vesicles derived from the plasma membrane
[Kumari et al., 2010]. This transport vesicles or endosomes subsequently deliver
their cargo to lysosomes for degradation or recycle it back to the cell surface. En-
docytosis can be categorized into two diﬀerent mechanisms [Conner and Schmid,
2003]: Phagocytosis, which is the uptake of larger particles, and Pinocytosis, where
smaller molecules are internalized. Phagocytosis is primarily restricted to specialized
immune cells, such as macrophages, monocytes and neutrophils, which clear various
pathogens or engulf dead cells. Pinocytosis on the other hand occurs in all cells and is
mediated by four distinct mechanisms: macropinocytosis, clathrin-mediated endocy-
tosis (CME), caveolae-mediated endocytosis, and clathrin- and caveolae-independent
endocytosis [Conner and Schmid, 2003]. The candidates identified in the fly screen
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primarily function in the pathway of the classical clathrin-mediated endocytosis, in
which Rab GTPases act as the key regulators.
Rab5 is a member of the Rab (Ras-like proteins in brain) family of proteins,
which represents the largest subgroup within the Ras superfamily consisting of more
than 70 members in humans [Jiang and Ramachandran, 2006]. Displaying the typ-
ical characteristics of a small GTPase, Rab5 acts as a molecular switch by cycling
between a cytoplasmic GDP-bound inactive and a GTP-bound active membrane-
associated state [Stenmark et al., 1994]. Applying an aﬃnity chromatography-
based approach, more than 20 putative interacting proteins for Rab5 were identified
[Christoforidis et al., 1999a; Stenmark, 2009]. These Rab5 binding partners can be
classified into two groups. The first class represents regulatory proteins, which pri-
marily modulate the status of guanine-nucleotide binding of Rab5 and include gua-
nine nucleotide exchange factors (GEFs), GTPase-activating proteins (GAPs) and
GDP dissociation inhibitors (GDIs). Particularly, Rabex-5 which forms a regulatory
complex with Rabaptin-5 was identified to catalyze GDP-GTP exchange on Rab5
[Horiuchi et al., 1997], whereas RabGAP-5 was shown to specifically active the in-
trinsic GTPase activity of Rab5 [Haas et al., 2005]. Additionally, GDI binds to
inactive GDP-associated Rab5 in the cytoplasm and acts as a chaperon, recycling
the small GTPase back to the membrane [Ullrich et al., 1994]. Once activated, Rab5
fulfills its function by interacting with the second class of binding partners, namely
the eﬀector proteins. One of the recruited eﬀectors is the Class III phosphatidyli-
nositol (PI) 3-kinase hVPS34, which binds to Rab5 via the adaptor protein p150
[Christoforidis et al., 1999b] and generates phosphatidylinositol 3-phosphate (PI3P)
at the membrane of early endosomes. These PI3P binding sites are recognized by
two other Rab5 eﬀectors that predominantly mediate vesicle docking and early endo-
some fusion: Namely early-endosome antigen 1 (EEA1) [Simonsen et al., 1998] and
Rabenosyn-5 [Nielsen et al., 2000]. In summary, Rab5 acts as a central element in the
tightly regulated process of endocytosis: On one hand the small GTPase functions as
a timer by cycling between an active membrane-associated and an inactive cytoplas-
mic state, thereby imposing temporal and spatial regulation to vesicular transport.
On the other hand, Rab5 operates as a molecular scaﬀold that sequentially recruits
a network of eﬀector proteins, enabling a coordinated progression of the individual
steps of endocytosis.
Another protein identified in the screen and involved in endocytosis is Syntaxin
7. In humans, 15 diﬀerent syntaxins have been identified that all belong to the
SNARE family of proteins (soluble N-ethylmaleimide-sensitive factor-attachment pro-
tein receptors) [Teng et al., 2001; Strömberg et al., 2009]. Together with other
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SNAREs, cytoplasmic NSF (N-ethylmaleimide-sensitive factor) and SNAP (soluble
NSF-attachment protein) proteins, the transmembrane syntaxin proteins mediate
membrane fusion in diverse vesicular transport processes along the exocytic and the
endocytic pathway [Teng et al., 2001]. When first identified, Syntaxin 7 (Stx7) was
shown to be ubiquitously expressed in various rat tissues and its subcellular localiza-
tion with the early endosome was revealed [Wong et al., 1998; Prekeris et al., 1999].
Later, it was found that Stx7 also localizes to late endosomes and it was implicated
in the mediation of endocytic traﬃcking from early to late endosomes and lysosomes
[Nakamura et al., 2000]. Furthermore, Syntaxin 7 forms two types of trans-SNARE
complexes with Vti1b and syntaxin 8 and either VAMP7 or VAMP8, thereby trigger-
ing either heterotypic late endosome to lysosome fusion or homotypic fusion of late
endosomes, respectively [Antonin et al., 2000; Pryor et al., 2004]. More recently,
human STX7 was shown to be diﬀerentially expressed in malignant melanoma and
lymphoma, whereas a decreased expression of the SNARE protein correlated with
more aggressive tumors [Strömberg et al., 2009].
Interestingly, human STX7 was identified to interact with the heteromeric Class C
Vps complex, consisting of hVPS11, hVPS18, hVPS16 and hVPS33a
[Kim et al., 2001]. Vps18 and Vps33 are the mammalian homologs of the Drosophila
eye color genes deep orange (dor) and carnation (car), respectively, which are im-
plicated in vesicle traﬃcking to lysosomes [Sevrioukov et al., 1999]. In combination
with other factors, this class C Vps core tetramer can form two diﬀerent complexes,
namely HOPS (homotypic fusion and protein sorting) [Nakamura et al., 1997] and
CORVET (class C core vacuole/ endosome tethering) [Peplowska et al., 2007]. These
large multimeric tethering complexes are best studied in yeast where they coordinate
Rab and SNARE function at the endosome and vacuole (the yeast lysosome) and
thereby provide specificity to vesicle fusion. In human cells, the HOPS complex was
identified to interact with Rab5 and to function as a GEF for Rab7 thereby medi-
ating the Rab5 to Rab7 conversion during early to late endosome progression [Rink
et al., 2005]. Moreover, immunohistochemistry as well as in vitro binding assays
showed that the mammalian tethering complex associates with actin filaments as
well as microtubules, suggesting that the HOPS complex may coordinate the at-
tachment and movement of endosomes along the cytoskeleton [Richardson et al.,
2004]. Interestingly, missense mutations in Vps33a in the mouse results in a pheno-
type that is similar to the human Hermansky–Pudlak syndrome (HPS), which is a
organelle biogenesis disorder characterized by albinism, bleeding, and in most cases
pulmonary fibrosis due to defects of melanosomes, platelet-dense granules, and lyso-
somes [Suzuki et al., 2003].
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Taken together, Rab5, Syntaxin 7, Vps16 and Vps33 all have important regulatory
functions in various steps along the endocytic pathway. Importantly, endocytosis
does not only control pivotal physiological processes such as nutrient uptake, liquid
and protein homeostasis of the plasma membrane, cell adhesion and immune surveil-
lance, it also mediates intercellular communication and signal transduction [Sorkin
and Zastrow, 2009]. Indeed, cell signaling is not simply regulated by controlling the
number of receptors available at the cell surface for activation, endosomes are recog-
nized as highly flexible scaﬀolds for sequential assembly of unique signaling complexes
that mediate spatiotemporal regulation of various signaling pathways [Zastrow and
Sorkin, 2007]. More recently, it has become clear that endosomes are essential in
such diverse processes as cell migration, polarization and even cytokinesis, by act-
ing as multifunctional platforms for the assembly of unique molecular machineries
[Gould and Lippincott-Schwartz, 2009]. Therefore, it will be interesting to deter-
mine whether the repression of either of the selected genes interferes with blood cell
homeostasis in mice and if even similar eﬀects can be observed by inhibiting these
various regulators along the vesicular traﬃcking pathway.
1.3.4 Papilin
Papilin was first discovered as a large extracellular matrix (ECM) glycoprotein with
O-linked, sulfated glycosaminoglycan chains that is secreted by cultured Drosophila
melanogaster cells and primarily localizes to the basement membrane of embryos
[Campbell et al., 1987]. Homologs of the extracellular matrix protein have been deter-
mined in nematodes, mouse and human. The papilin found in Mus musculus shows
a protein identity of 39% to its Drosophila homolog (http://www.ebi.ac.uk/Tools
/sss/ncbiblast). Moreover, Papilin contains a distinctly conserved domain, the so
called “papilin cassette”, consisting of a set of thrombospondin type 1 domains
(TSR) separated by a cysteine-rich spacer region. Additionally, this domain shares
homology with the noncatalytic portion of the ADAMTS (A Disintegrin And Metal-
loprotease with Thrombospondin type 1 motifs) family of secreted metalloproteases
[Fessler et al., 2004]. Interestingly, papilin harbors multiple copies of domains similar
to other protease inhibitors, such as the Kunitz domains of BPTI (Bovine Pancreatic
Trypsin Inhibitor) type, and was shown to non-competitively inhibit an ADAMTS
metalloproteinase in vitro [Kramerova et al., 2000]. Furthermore, in Drosophila pa-
pilin is expressed in head mesoderm derived hemocytes, which subsequently give rise
to the extracellular matrix [Kramerova et al., 2003; Wood and Jacinto, 2007]. Thus,
papilin is not only expressed throughout development in the ECM, it also seems to be
essential for embryogenesis in Drosophila and Caenorhabditis elegans since its repres-
21
sion in the embryo by RNAi is lethal [Kramerova et al., 2000]. Taken together, these
results suggest a possible regulatory role for papilin in development, organogenesis
and angiogenesis by modulating the activity of ADAMTS metalloproteinases.
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1.4 Project outline
The similarity of hematopoietic development in the fruit fly Drosophila melanogaster
and mammals, considering its spatiotemporal regulation and the molecular factors
controlling blood cell diﬀerentiation [Waltzer et al., 2010], suggest that several basic
mechanisms of hematopoiesis are conserved during evolution between insects and
vertebrates. Based on this knowledge, an in vivo RNAi screen in developing hemo-
cytes in fly larvae was applied to identify novel conserved regulators of hematopoietic
diﬀerentiation and homeostasis [Elling et al., unpublished]. In this survey the down-
regulation of certain genes resulted in a marked overproliferation of macrophage-like
plasmatocytes in third instar Drosophila larvae. The screen identified not only known
regulators of hematopoiesis in the fruit fly but it also uncovered novel genes, which
have not been implicated in hematopoiesis so far. The aim of this study therefore,
was to select promising hits of the screen and evaluate the relevance of this novel
candidate genes in the mammalian hematopoietic system. In order to do this, we
first analyzed if the knock-down of these genes promotes proliferation and growth
of a murine B-cell line in vitro. Furthermore, we established down-regulation of the
selected genes in mouse bone marrow precursor cells and analyzed their potential
to repopulate lethally irradiated hosts in vivo. This bone marrow chimeric approach
showed that indeed three out of six of the identified genes influence hematopoiesis
by promoting the abundance of the myeloid lineage while interfering with the recon-
stitution of the lymphoid lineage.
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2 Results
2.1 Candidate genes are expressed in
hematopoietic tissues in the mouse
To select promising candidate genes, expression profiles from published gene annota-
tion resources (http://biogps.gnf.org) [Wu et al., 2009] and data in the literature was
used as a reference. Since these data are sometimes incomplete and misleading, we
confirmed mRNA expression of the selected candidates by RT-PCR. Importantly, all
genes are expressed in hematopoietic tissues in the mouse, such as the bone marrow,
spleen and thymus, as well as in the mouse pro-B cell line Ba/F3 (Figure 2.1).
Figure 2.1: Candidate genes are expressed in hematopoietic tissues in mice. Total
mRNA was isolated from BaF/3 cells (lane 1), thymus (lane 2), spleen (lane 3) as
well as bone marrow (lane 4). Expression of indicated mRNA was determined by
RT-PCR. Lanes marked with (-) show negative H2O control.
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2.2 Knock-down of candidate genes does not eﬀect
cell proliferation in vitro
Considering the fact that knock-down of the selected genes caused massive over-
growth of plasmatocytes in Drosophila larvae, it was tempting to test whether their
repression would promote proliferation of a hematopoietic cell line in vitro. There-
fore we decided to use the mouse pro-B cell line Ba/F3, which expresses all the
candidate genes (Figure 2.1), to generate cells stably expressing a short hairpin RNA
(shRNA), which selectively down-regulates gene expression. For each gene, three in-
dependent small hairpin RNAs (shRNAs) were cloned into the modified retroviral vec-
tor MSCV-LMP (http://www.openbiosystems.com/RNAi/RetroviralCloningVectors)
(Figure 2.2A), hereafter referred to as pMIG. The miR30 styled shRNAs were first
amplified from a 97 nucleotide long, single stranded DNA template by PCR (Figure
2.2B) and after subsequent restriction digest, ligated into the linearized pMIG vec-
tor. The incorporation of the gene specific hairpin into the backbone of the mir-30
microRNA improves its processing by endogenous Drosha and Dicer and promotes
active loading into the RISC complex, thereby ensuring a more eﬃcient knock-down
[Zeng et al., 2002b].
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18. Ligate for 3 hours at room temperature. Dilute the ligation mix by adding 160 μl DEPC water.
19. Transform 5 μl of the diluted ligation mix into competent E.coli. We recommend Thermo Scientific Open 
Biosystems PrimePlus E. coli for maximum stability of the viral plasmid (Thermo Scientific Open Biosystems 
Catalog #MBC4246). Follow the transformation protocol for the competent cells. Plate the transformed cells 
onto agar plates containing 100 μg/ml ampicillin (carbenicillin). Be sure to transform the same volume of 
ligation mix and plate the same volume of cells for both the control and the experimental sample. Plating  
100 μl, 50 μl, and 10 μl aliquots is recommended.
20. Incubate plates at 30°C overnight. Count colonies and determine the ratio of colonies on the control plate 
versus the experimental plates. Determine the number of colonies to screen.
21. Sequence verify clones using the recommended sequencing primer: 
5’-CCCTTGAACCTCCTCGTTCGACC-3
??Aligns to TMP vector sequence base pairs 1498-1520*
??Aligns to LMP vector sequence base pairs 1333-1355* 
*This primer was designed and used by the developer of the TMP and LMP plasmids, Dr. Ross Dickens. It 
lies several hundred base pairs from the hairpin insertion site. An alternate sequencing primer can be designed 
using the PGK promoter region of each plasmid.
Protocol 2- Starting With shRNA Design
To generate new shRNAmir clones, go to RNAi Central- RNAi Oligo Retriever  
(http://katahdin.cshl.org:9331/homepage/siRNA/RNAi.cgi?type=shRNA).
Enter the accession number of your target gene, or paste in a nucleotide sequence (useful for targeting alternative 
exons, for example). There is also an option to paste in a short siRNA sequence, which allows design of a miR30-
based shRNA template oligonucleotide corresponding to a known siRNA. The RNAi oligo retriever will generate 
the hairpin primer by selecting a ‘sense’ sequence of 22 nucleotides (nt) in length from the coding sequence of the 
gene of interest for each clone to be constructed. Some common rules that RNAi oligo retriever applies include:
??Targeting to coding sequences or 3’ UTR
??Selection of shRNA to contain >3 mismatches to any other gene
??Avoids known SNPs
??Avoids common exons targeted in 
alternatively spliced mRNAs
??Destabilize the 5’ end of the antisense 
strand to bias the incorporation of 
the antisense strand into RISC
1. Use the ‘RNAi oligo retriever’ at RNAi 
Central: shRNA pSM2 design. The 
design of the template oligonucleotide 
incorporates miR-30 microRNA 
(miRNA) sequences (as DNA) into 
the target sequence. This is already 
done by the RNAi oligo retriever 
program by:
a. Inserting the miR-30 loop sequence 
between the sense and the antisense 
sequences.  
b. Adding the appropriate flanking 
sequences of miR-30 miRNA to the 
5’ end and the 3’ end of the target. 
Note:  This setup yields a molar ratio of 1 vector to 1 insert.
Component No Insert Control shRNAmir Ligation
shRNAmir insert cut with EcoRI and XhoI (total 7.4 ng) XXXXXXXXX ____ μl
TMP/LMP vector cut with EcoRI and XhoI (total 250 ng) ____ μl ____ μl
DEPC water ____ μl ____ μl
10X ligase buffer 2.0 μl 2.0 μl
Ligase 0.5 μl 0.5 μl
Total volume 20.0 μl 20.0 μl
Table 9. Ligation reactions
Figure 6. Design and sequence of a sample template. Above the final preprocessed 
structures of the mir-styled shRNA with derivations of each part of the sequence. 
Below the corresponding oligonucleotide DNA template sequence design derived 
from the oligonucleotide RNA. The sequence in red represents the flanking miR-30 
sequences and those in green the miR-30 loop structure. The sample sense and 
antisense-selected target sequences are shown in black and in blue, respectively. 
The miR-30-styled shRNA is synthesized as a single stranded DNA oligonucleotide 
with common ends corresponding to part of the endogenous miR-30 miRNA flanking 
sequence. The flanking regions, shown in red are used as universal flanks to prime 
a reaction, whereby the entire miR-30- styled shRNA is amplified to produce a PCR 
product that can be cloned into a recipient vector (Paddison et al 2004)
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Figure 2.2: (A) Vector map of MSCV-LMP. In the modified vector, named pMIG, the
PGK promoter driving the expression of the puromy in resistance was inactivat d.T
miR30-based gene-specific shRNAs are inserted into the miR30 backbone using the
restriction sit s XhoI and EcoRI. (B) Schematic design of miR-30-styled shRNAs. In
the upper picture the final preprocessed s ructure of th se se (b ck) an a ti ense
(blue) targ t sequences inserted in the backbone of the miR-30 microRNA is shown.
Below the sequence of the corresponding single stranded DNA oligonucleotide used
for PCR amplification is shown. Sequences in red or green represent the flanking
miR-30 nucleotides or the miR-30 loop structure, respectively.
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After successful cloning of all constructs, the mRNA levels of the targeted genes
were determined in the stable Ba/F3 cell lines to verify eﬃcient knockdown. In all
cases, at least one of the three hairpins was capable of decreasing the endogenous
transcript levels more than 60% from the baseline (Figure 2.3). In fact, most knock-
down cell lines showed a remaining mRNA expression of about 30%, except for Rab5a
and Stx7 were transcript levels could even be reduced to more than 90% from baseline
levels. For each gene, the hairpin showing the most potent knock-down eﬃcacy was
used for further analysis.
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Figure 2.3: Knock-down eﬃciency of three individual hairpins. Total mRNA was
isolated from mouse Ba/F3 cells stably expressing a gene-specific shRNAs target-
ing the indicated genes. Expression levels of mRNA were determined by qRT-PCR
relative to ß-actin levels. Data are shown as percentage of the remaining transcript
levels compared to the control cell line stably transfected with the empty vector pMIG
(mean values ± SD).
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In order to analyse the eﬀect of the knock-down on proliferation, we compared
the growth rate of the knock-down cell lines to wild-type cells or cells harboring the
empty vector. No significant increase in cell growth could be detected for all cell lines
tested (Figure 2.4). The lack of an obvious growth advantage might have several
reasons. For instance, plasmatocytes closely resemble macrophages or monocytes of
the myeloid lineage in vertebrates, thus the functionality of the identified genes might
not readily be applicable to mouse Ba/F3 cells, which is an immortalized lymphoid
pro-B cell line [Palacios and Steinmetz, 1985]. Additionally, important factors of
the microenvironment such as signaling molecules and cell to cell interaction, which
might contribute to the observed phenotype in vivo are not recapitulated in an in
vitro system. Thus, we decided to analyze the eﬀect of gene repression in the
hematopoietic system in vivo.
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Figure 2.4: In vitro proliferation of the stable knock-down cell lines is similar to
wild-type cells. Mouse pro-B cells (Ba/F3) stably expressing the indicated shRNAs,
growing under standard conditions, were counted and split all 3 days for 2 weeks.
Exponential growth is shown as logarithmic function of the cell number on the in-
dicated days for cells stably expressing shRNAs (sh) against Ssrp1 (A), Sympk (B),
Rab5a(C), Stx7 (D), Vps16 (E) and Vps33a (F). Wild-type and only GFP-expressing
(pMIG) Ba/F3 cells serve as negative controls. For Ssrp1, Rab5a, Stx7 and Vps16
proliferation of cell lines expressing the two most potent shRNAs was validated (sh1
and sh2).
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2.3 Generation of bone marrow chimeras
The “gold standard” for studying the molecular function of potential oncogenes and
tumor suppressor genes involves the generation of transgenic and knock-out mice
harboring the altered, oncogenic lesion in the germline. Nevertheless their production
is time-consuming and laborious. Therefore, we took advantage of a faster chimeric
approach, where knock-down of the candidate genes is established in isolated bone
marrow cells in vitro. These cells are subsequently transplanted into recipient mice
previously depleted of hematopoietic cells by irradiation (Figure 2.5). The gene
silencing constructs were introduced into bone marrow cells with retroviruses, derived
from an ecotropic packaging cell line (Plat-E). All the retroviral constructs contained
an internal ribosome entry site (IRES) followed by the green fluorescent protein (GFP)
next to the gene specific shRNA (Figure 2.2A), allowing us to distinguish transduced
and wild-type cells.
Figure 2.5: Generation of bone marrow chimeric mice. Bone marrow cells isolated
from 5’-fluorouracil (5-FU) treated C57BL/6J mice were activated with the indicated
cytokines for 24 hours, followed by 4 cycles of retroviral infection. Retroviruses
harboring the shRNA-IRES-GFP construct targeting the selected genes, were derived
from PLAT-E packaging cells. 1.2 x 106 transduced cells were transplanted into
lethally irradiated (9.5 Gy) recipient mice via tail vein injection. Eight weeks after
reconstitution, chimeric mice were analysed by Flow cytometry.
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To confirm eﬃcient knock-down of the candidate genes in vivo, we isolated B220+
B-cells from the spleens of chimeric mice by fluorescent activated cell sorting (FACS)
and tested the expression of the respective transcripts by quantitative RT-PCR (Fig-
ure 2.6). For all six genes, except for Vps33a, the knock-down was less potent in the
isolated splenocytes than in the Ba/F3 cell line. The transcript levels were reduced
more than 60% in four cases, namely Ssrp1, Rab5a, Stx7 and Vps33a. However, for
Symplekin and Vps16, gene silencing seems to be less eﬃcient in vivo because the
B220+ B-cells still harbor approximately 60 or 70% of the respective mRNA, when
compared to splenocytes isolated from pMIG control mice.
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Figure 2.6: In vivo knock-down eﬃciency in B220+ splenocytes of bone marrow
chimeric mice. Splenocytes isolated from bone marrow chimeras, harboring GFP+
cells expressing shRNAs against the selected genes, were labelled with an APC-
conjugated anti-B220 antibody and B220+ GFP+ lymphocytes were sorted by FACS.
Total mRNA was isolated and transcript levels of the indicated genes were deter-
mined by quantitative RT-PCR. ß-actin was used as internal control. The green
bars represent the percentage of remaining transcript after knock-down compared to
control B220+ GFP+ cells isolated from pMIG chimeras. The blue bars show the
corresponding in vitro knock-down eﬃciency determined in stable BaF/3 cell lines
(n = 2; mean values ± SD).
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In order to gain an insight into the eﬃciency and reproducibility of bone marrow
infection and reconstitution of recipient mice, we performed two kinds of analysis:
First, we calculated how the transfection eﬃciency of the packaging cell line Plat-E
translates into bone marrow infection rates. Since we did not determine the actual
viral titer, this relative infection rate serves as an approximation to quantify infection
eﬃciency. The relative infection rate was obtained by dividing the percentage of
infected GFP+ bone marrow cells by the percentage of transfected GFP+ Plat-E cells.
The transfection eﬃciency is widely dependent on the cell line, therefore a constant
ratio similar to the control situation (pMIG) of about 70 would be expected. For Ssrp1
and Symplekin the relative infection rate is in accordance with the ratio observed in
the control situation. In all other cases the value is about 50 (Figure 2.7A). This
overall decrease could have several reasons, for example increased apoptosis of bone
marrow cells in culture. Moreover, the reduced ratio as observed for Rab5a, Stx7
or Vps33a shRNA transfected bone marrow could already implicate an eﬀect of the
knock-down on the cells.
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Figure 2.7: Relative infection and reconstitution eﬃciencies. (A) Percentage of
infected bone marrow cells was divided by the percentage of transfected Plat-E cells.
Bars represent relative infection rate of bone marrow cells expressing shRNAs against
the indicated genes. pMIGI and pMIGII correspond to two independent negative
controls only expressing GFP derived from two diﬀerent experiments. (B) Percentage
of GFP+ cells after reconstitution in vivo divided by the percentage of GFP+ bone
marrow cells before transplantation. Each data point represents the value of a single
mouse for the indicated genotype, horizontal line indicates mean ± SEM (n = 3; *
P < 0.05).
Since there was a high variability in the percentage of GFP+ cells in the reconsti-
tuted mice, we analyzed how this relates to bone marrow infection eﬃciency. There-
fore we divided the percentage of GFP+after reconstitution in vivo by the percentage
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of infected bone marrow cells before injection. Considering that a mixed population
of infected and uninfected bone marrow cells was injected, the ratio of GFP+ to GFP-
cells should stay the same after the reconstitution and should therefore give a relative
reconstitution value of 100. In the first cohort of mice, the pMIGI control mice showed
a mean relative reconstitution rate of about 100 (Figure 2.7B), whereas the ratio for
Stx7 was significantly decreased in all three mice. This indicates that although the
bone marrow cells were properly infected prior to transplantation, the infected cells
were not able to contribute to the reconstitution of the recipient to the same extent
as uninfected cells. Interestingly, the relative infection value for Stx7 (Figure 2.7A)
shows that the infection in vitro was less eﬃcient despite a similar Plat-E cell trans-
fection and thus a similar viral titer. Strikingly, all three Vps33a recipients showed
a significant increase in the percentage of GFP+ cells after reconstitution compared
to control mice. In the second cohort, the pMIGII control mice did not show the
expected relative reconstitution rate of 100. Two mice displayed a decreased number
of GFP+ cells after reconstitution, whereas one maintained the same ratio as before
injection. Although the three mice for each genotype were transplanted with the
same bone marrow, a loss or an increase of infected cells after transplantation can be
observed in individual mice, indicating that factors independent of the knock-down
influence the reconstitution eﬃciency.
For the analysis of the bone marrow chimeras and the eﬀect of the knock-down on
the various blood cell types, we focused on the GFP+ cells and compared the lineage
distribution of the experimental knock-down to the pMIG control populations. The
choice for this approach is based on the idea that the knock-down of a certain gene
in a precursor cell might positively or negatively influence its diﬀerentiation capacity
and subsequently enhance or inhibit the formation of a certain blood cell lineage.
Thus, the abundance of the main hematopoietic lineages was determined in the bone
marrow, spleen, thymus and peripheral blood of the recipient mice by flow cytometry
eight weeks after reconstitution.
In order to validate this approach, we compared the results of the two independent
control cohorts pMIGI and pMIGII, which were generated in independent experiments.
Since all the GFP+cells in these mice only harbor the empty retroviral vector and
no silencing shRNA, the GFP+ population should contribute equally to all lineages.
Chimeric mice were sacrificed eight weeks after the transplantation of GFP+ bone
marrow cells and the bone marrow, spleen, thymus and peripheral blood was isolated.
After red blood cell lysis, the single cell suspensions of these tissues were stained
with fluorescently labelled antibodies and the blood lineage distribution was analyzed
by flow cytometry. Figures 2.8 and 2.9 show examples how the gates were set in
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thymus and bone marrow samples to analyze the data. First, all viable cells were
selected in the forward-side scatter to exclude dead cells and aggregates. Then,
these cells were divided into a GFP+ and a GFP− subset, followed by gating on the
population of interest in the forward-side scatter. The gate R1 includes all small cells
like lymphocytes and erythroblasts, whereas the R2 gate includes bigger granular
cells such as monocytes and granulocytes. Among these cells, the individual sub-
populations positive for the indicated markers were analyzed either using a histogram
or a dot blot. The analysis in the spleen and the peripheral blood was performed
similar to the bone marrow samples. All flow cytometry data were analyzed according
to this protocol. To simplify data presentation, the abundance of the individual
populations was visualized in bar graphs as percentage of the GFP+ or the GFP−
gate.
Figure 2.8: Representative example of the gating strategy in the thymus to analyze
the flow cytometry data. In the first gate, all viable cells were selected, followed
by subsequent gating on the GFP+ and GFP− subsets. The R1 gate was further
analyzed for expression of the indicated T-cell markers.
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Figure 2.9: Representative example of the gating strategy in the bone marrow to
analyze the flow cytometry data. In the first gate, all viable cells were selected,
followed by subsequent gating on the GFP+ and GFP− subsets. These cells are
divided into the R1 and R2 populations in the forward-side scatter, followed by
analysis of the expression of the indicated marker using either a histogram or a dot
blot. Gates were set similarly in the spleen and peripheral blood.
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Figure 2.10: Lineage contribution of GFP+ cells is similar among pMIG control mice.
Flow cytometric analysis of the major blood cell lineages in independent control mice
pMIGI and pMIGII 8 weeks after bone marrow transplantation: (A) B-cells, (B)
T-cells, (C) myeloid cells and (D) erythroblasts and NK-cells, isolated from bone
marrow, spleen, thymus and peripheral blood. Columns represent the percentage of
GFP+ (dark grey = pMIGI, dark green = pMIGII) or GFP− (light grey = pMIGI, light
green = pMIGII) cells positive for the indicated markers (n = 1). (E) Distribution of
viable GFP+ cells in the indicated tissues (BM = bone marrow).
36
Considering that the mice were analyzed on three diﬀerent days and we noticed
variances in the data collected separately, probably due to diﬀerences in staining
and compensation of the cytometer, we only compared results for mice that were
examined on the same day. In the control mice, all percentages of GFP+cells were
similar in most lineages and no major diﬀerences could be observed (Figure 2.10).
Of note, the pMIGII control mouse show a higher percentage of GFP+ Gr-1+Mac-1+
cells (15.1%) in the peripheral blood as the pMIGI control mouse (9.47%) (Figure
2.10C). Moreover, there is a diﬀerence of more than 6% in the abundance of Ter119+
erythroblasts in the GFP+ compartment of pMIGI and pMIGII control mice. How-
ever, the ability of the transplanted GFP+ bone marrow cells to contribute to the
erythroblast lineage is generally impaired, a fact that becomes already evident by
absence of this population in the forward-side scatter in the R1 gate of the GFP+
subset (Figure 2.9).
On the other hand, another way to analyze the data would be to compare the
percentages of GFP+ cells positive for a certain marker to the same population in
the GFP− subset in the same mouse. In the comparison of pMIGI and pMIGII control
mice, the ratio of GFP+ to GFP− cells is in most cases constant throughout a certain
lineage (Figure 2.10). Therefore, changes in this ratio due to the knock-down of a
certain gene by means of an increase of the GFP+ population that correlates with a
decrease in the GFP− subset, might rule out certain compensatory eﬀects to adjust
total cell number.
In summary, the analysis of the control groups showed that the comparison of the
GFP+subsets between mice and in regard to the same population in the GFP− subset
in the same mouse is valid to identify if the knock-down of a gene is advantageous
or disadvantageous for a cell to contribute to a certain lineage.
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2.3.1 Reconstitution of hematopoietic lineages with Ssrp1
down-regulated bone marrow cells
Initially, Ssrp1 caught our attention because it is highly expressed in the bone marrow,
spleen, thymus and lymph nodes of mice [Hertel et al., 1999] (Figure 2.1), suggesting
a potential function in the hematopoietic compartment. As subunit of the FACT
complex, Ssrp1 is implicated in various vital cellular processes such as replication,
DNA repair and transcription [Formosa, 2008]. Independent from the FACT complex,
Ssrp1 also serves as a transcriptional co-activator interacting with other transcription
factors such as serum response factor or p63 [Spencer et al., 1999; Zeng et al., 2002a].
Interestingly, gene repression of the Drosophila homolog in hemocytes caused besides
a severe expansion of plasmatocytes in fly larvae also an increase of crystal cells and
promoted the formation of melanotic tumors. However, the function of Ssrp1 in the
hematopoietic compartment in mammals has not been addressed so far.
In order to test whether Ssrp1 knock-down also eﬀects proliferation and viability
of hematopoietic cells in mice, bone marrow cells expressing a shRNA against Ssrp1
were transplanted into irradiated hosts and the composition of hematopoietic cells
was analyzed by flow cytometry 8 weeks after reconstitution. For each mouse the
percentage of GFP+ or GFP− cells contributing to the major blood cell lineages was
determined. The mean values of the pooled results of all three mice per genotype
are shown as bar graphs in Figure 2.11. The percentage of GFP+ cells accounts
for about 40-50% in all analyzed tissues (Figure 2.11E). In the GFP+ subset, the
knock-down of Ssrp1 does not result in significantly diﬀerent percentages of B- , T-
or myeloid cells (Figure 2.11A-C). Additionally, the knock-down does not interfere
with the reconstitution of the NK-cell or erythroblast compartment (Figure 2.11D).
Of note, contribution of GFP+ cells to the erythroblast compartment is markedly
reduced compared to the GFP− subset in both Ssrp1 knock-down and pMIG control
chimeras.
In summary this data indicate that Ssrp1 is not essential for the reconstitution and
homeostasis of the hematopoietic system, since neither a significant reduction nor
increase in the percentage of any blood cell lineage can be observed.
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Figure 2.11: Comparative flow cytometric analysis of hematopoietic lineages in mice
transplanted with Ssrp1 shRNA or empty vector (pMIG) infected bone marrow cells 8
weeks after injection. Percentages of GFP+ (dark grey = pMIG, dark green = Ssrp1)
or GFP− (light grey = pMIG, light green = Ssrp1) cells positive for the indicated
lineage markers are shown in bars (mean values ± SEM, unpaired t test, n = 3 mice
per group, * P < 0.05, ** P < 0.01). Individual panels show pooled results for the
major blood cell compartments in the indicated tissues: (A) B-cells, (B) T-cells, (C)
myeloid cells and (D) erythroblasts and NK-cells. (E) Mean distribution of GFP+
cells in Ssrp1 knock-down (green) and pMIG control (grey) chimeras in the analyzed
tissues. BM = bone marrow.
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2.3.2 Analysis of bone marrow chimeras reconstituted with
Symplekin down-regulated bone marrow cells
Symplekin is implicated in the control of polyadenylation-regulated translation, which
is important in cell cycle progression and development [Lutz, 2008]. Moreover, Sym-
plekin interacts with various transcription factors, such as the heat shock protein
1 or ZONAB, thereby regulating the expression of stress response genes as well as
of cell cycle genes like Cyclin D1 [Xing et al., 2004; Buchert et al., 2009]. The
amino acid sequence of the tight junction protein Symplekin is moderately con-
served to its Drosophila homolog with 35% identical residues (http://www.ebi.ac.uk/
Tools/sss/ncbiblast). Interestingly, knock-down of Symplekin in fly hemocytes re-
sulted in severe overproliferation of plasmatocytes and crystal cells in the developing
larvae.
Thus, we analyzed its role in hematopoietic proliferation and homeostasis in mice by
the transplantation of bone marrow cells with down-regulated Sympk expression. The
lineage distribution of the GFP+ cells, deficient in Sympk expression as well as GFP−
wild-type cells in the bone marrow, spleen, thymus and peripheral blood was analyzed
in recipient mice 8 weeks after reconstitution. Flow cytometric analysis showed that
down-regulation of Sympk expression has various eﬀects on the B-cell compartment.
The percentage of GFP+B220+ lymphocytes is significantly decreased in the bone
marrow, spleen as well as the peripheral blood compared to pMIG control mice. At
the same time, the proportion of the B220+ population in the GFP− subset is elevated
in the bone marrow and the spleen compared to pMIG control mice as well as to
the GFP+B220+ subset in Sympk knock-down chimeras, indicating a compensatory
eﬀect. Moreover, the percentage of IgM+IgD− and IgM+IgD+ lymphocytes in the
GFP+B220+ compartment is reduced in the bone marrow of Sympk knock-down
chimeras. These mice also show a slight but significant decrease in the percentage of
B220+IgM+ and B220+IgD+ as well as B220+CD93+ and B220+CD93− splenocytes.
The knock-down of Sympk further causes a significant reduction of CD19+ B-cells
as well CD19+CD25+ pre-B cells in the bone marrow (Figure 2.12A). In the T-cell
compartment, the percentage of CD3+ T-cells in the peripheral blood is significantly
lower in Sympk knock-down chimeras than in pMIG control mice. This reduction
is accompanied by a decreased proportion of CD4+ helper T-cells in the blood,
which show a slight but significant increase in the thymus. On the other hand, T-cell
populations in the spleen are unaﬀected by the knock-down of Sympk (Figure 2.12B).
Interestingly, the bone marrow of Sympk knock-down chimeras harbors a signif-
icantly increased percentage of GFP+c-kit+ myeloid precursor cells. Moreover, the
proportions of Gr-1+Mac-1+ immature myeloid cells is elevated in the bone marrow
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Figure 2.12: Flow cytometry data of mice reconstituted with Sympk deficient or
control (pMIG) bone marrow 8 weeks after transplantation. Columns show the per-
centage of infected GFP+ (dark grey = pMIG, dark blue = Sympk) and GFP- (light
grey = pMIG, light blue = Sympk) cells expressing the indicated markers (mean
values ±SEM; unpaired two-tailed t test; n = 3; * P < 0.05; ** P < 0.01; *** P <
0.001). Major lineages analyzed in the indicated tissues are clustered in subsequent
panels: (A) B-cells, (B) T-cells, (C) myeloid cells and (D) erythroblasts and NK-
cells. (E) Mean percentage of viable GFP+ cells (±SEM) in the analyzed tissues are
represented as bar graphs. BM = bone marrow.
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and spleens of these mice compared to pMIG control chimeras. Additionally, the
knock-down of Sympk results in a higher percentage of CD11c+ dendritic cells in the
bone marrow as well as the spleen. Interestingly, the ratios of Gr-1+Mac-1+ immature
myeloid cells as well as CD11c+ dendritic cells in the GFP− compartment are simi-
lar among Sympk knock-down chimeras and pMIG controls. In contrast, the c-kit+
population shows a significantly decreased proportion in the GFP− subset of mice
harboring Sympk down-regulated bone marrow and compared to pMIG control mice,
again suggesting a compensatory eﬀect (Figure 2.12C). Finally, in the spleen the per-
centage of NK1.1+ natural killer cells is significantly increased in Sympk knock-down
chimeras compared to pMIG control mice, while the ratio of this population is normal
in the bone marrow (Figure 2.12D).
Taken together, these results indicate that Symplekin down-regulation negatively
aﬀects B-lymphocytes, whereas it positively contributes to the repopulation of the
myeloid compartment, especially of immature myeloid precursor cells.
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2.3.3 Repression of Rab5a or the overexpression of a
dominant-negative Rab5a mutant show diﬀerential
eﬀects on bone marrow reconstitution
In the mouse, three isoforms of the Drosophila Rab5, namely Rab5a, Rab5b and
Rab5c have been identified [Bucci et al., 1995]. The murine Rab5a shows 74%
identity at the protein level to the fly Rab5, followed by Rab5c with 73% identity
and Rab5b with 71% (http://www.ebi.ac.uk/Tools/sss/ncbiblast). Functionally, all
three mammalian isoforms of the small GTPase Rab5 cooperate in the regulation
of endocytosis [Bucci et al., 1995]. The fly screen conducted to identify novel con-
served factors that regulate hematopoiesis during Drosophila development identified
Rab5 as negative regulator of plasmatocyte proliferation and homeostasis. More-
over, knock-down of Rab5 in fly hemocytes resulted in an increase of the crystal
cell compartment and promoted melanotic tumor formation. Considering that the
function of Rab5a might be redundant in the mouse due to compensation by its
isoforms Rab5b and Rab5c [Huang et al., 2004], two diﬀerent approaches were cho-
sen to address the role of the small GTPase in the hematopoietic system: First, a
specific shRNA was used for gene silencing. Second, a dominant-negative mutant
of Rab5a was overexpressed to interfere with the function of the wild-type protein.
In the dominant-negative form, a serine was mutated to an asparagine at residue 34
(Rab5a:S34N) as described previously [Li and Stahl, 1993]. Due to this substitution,
the protein has a 100 times higher aﬃnity for GDP than GTP, thereby staying in
the inactive GDP-bound state. Furthermore, this mutated form of Rab5a appears to
have a more pronounced phenotypical eﬀect on receptor-mediated endocytosis than a
siRNA-driven knock-down [Dinneen and Ceresa, 2004; Huang et al., 2004]. To gen-
erate the dominant-negative mutant, the coding region of Rab5a was amplified from
total cDNA extracted from mouse bone marrow cells and mutated by PCR based
site-directed mutagenesis. The construct was then cloned into the same retroviral
vector as the short hairpin RNAs (pMIG) for overexpression in bone marrow cells.
Hematopoietic cells overexpressing this inactive version of Rab5a or a specific shRNA
were again transplanted to lethally-irradiated recipient mice and their contribution to
the reconstitution of the hematopoietic system was analyzed by flow cytometry after
8 weeks.
In the B-cell compartment, Rab5a knock-down chimeras show a significantly de-
creased percentage of GFP+B220+ lymphocytes in the peripheral blood as well as
reduced proportions of CD19+CD25+ pro-B cells in the bone marrow (Figure 2.13A).
However, mice expressing the mutated form of Rab5a display normal ratios of B-
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cells in the bone marrow, spleen and blood compared to pMIG control mice (Figure
2.14A). Furthermore, in recipients reconstituted with Rab5a knock-down bone mar-
row a significantly reduced percentage of peripheral CD4+ T-cell can be observed
in the blood, while the ratio of this population in the thymus and the spleen was
similar to pMIG control mice (Figure 2.13B). Interestingly, the percentage of CD4+
helper T cells is also significantly reduced in the spleen of Rab5DN over-expressing
chimeras. Furthermore, this T-cell population is slightly but not significantly reduced
in the peripheral blood (Figure 2.14B).
In the myeloid compartment, diﬀerent eﬀects of the knock-down of Rab5a and the
overexpression on immature myeloid cells can be observed. Mice reconstituted with
Rab5a down-regulated bone marrow cells harbor a slight but significant increase of
Gr-1+Mac-1+ immature myeloid cell in the spleen compared to pMIG control mice
(Figure 2.13C), while this population is significantly elevated in the bone marrow
of mice over-expressing the mutant form of Rab5a (Figure 2.14C). Moreover, the
NK1.1+ natural killer cells show a significantly increased percentage in the spleen
of Rab5a knock-down chimeras (Figure 2.13D), while no significant changes can be
observed in the dominant-negative mutant over-expressing chimeras (Figure 2.14D).
The chimeras harboring the Rab5a down-regulated bone marrow transplant display
a significantly decreased percentages of Ter119+ erythroblasts in the bone marrow
(Figure 2.13D), while this reduction is not observed in the dominant-negative situ-
ation (Figure 2.14D). Nevertheless, the GFP+ subset generally contributes only to
a minor degree to erythroblasts reconstitution even in the pMIG control mice, thus
changes in the GFP+ erythroblast compartment might be highly variable. However,
the inability of the GFP+ population to reconstitute Ter119+ erythroblasts might be
an explanation why the attempt to reconstitute lethally-irradiated recipient mice with
100% GFP+ bone marrow cells overexpressing the dominant-negative Rab5a failed.
These mice died of severe anemia three weeks after transplantation. Importantly,
this transplantation experiment was only lethal for mice receiving the Rab5DN over-
expressing bone marrow. Control mice reconstituted with 100% GFP+ bone marrow
cells harboring the empty pMIG vector were healthy three weeks after transplanta-
tion. Furthermore, irradiation control mice that did not receive any bone marrow
cells died after 12 days, in approximately 10 days before the recipients of the Rab5a
mutant over-expressing bone marrow. Additionally, dominant-negative mutant over-
expressing chimeras showed significantly lower numbers of white and red blood cells
and platelets in the peripheral blood when compared to the pMIG control mice (Fig-
ure 2.15A, B, C). Moreover, we observed a significantly lower thymus and spleen
weight in these mice (Figure 2.15D and E).
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Figure 2.13: (A) B-cells, (B) T-cells, (C) myeloid cells and (D) erythroblasts and
NK-cells, were analyzed in chimeras reconstituted with Rab5a shRNA knock-down or
control (pMIG) bone marrow after 8 weeks. Percentages of transplanted GFP+ (dark
grey = pMIG, dark blue = Rab5a) and GFP- (light grey = pMIG, light blue = Rab5a)
cells contributing to the depicted lineages were determined by flow cytometry. Data
are shown as mean values ± SEM (n = 3 mice per group; unpaired two-tailed t test;
* P < 0.05; ** P < 0.01; *** P < 0.001). (E) Distribution of GFP+ cells in the
analyzed tissues (n = 3). BM = bone marrow.
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Figure 2.14: Flow cytometric analysis of bone marrow chimeras overexpressing a
dominant-negative form of Rab5a in comparison with control (pMIG) mice. Major
hematopoietic compartments are grouped in separate panels: (A) B-cells, (B) T-cells,
(C) myeloid cells and (D) erythroblasts and NK-cells. Columns represent mean values
of the percentage of GFP+ (dark grey = pMIG, dark blue = Rab5DN) and GFP-
(light grey = pMIG, light blue = Rab5DN) cells positive for the indicated markers
(mean ± SEM, n = 3 mice per group; unpaired two-tailed t test; * P < 0.05). (E)
Distribution of GFP+ cells in the analyzed tissues (n = 3). BM = bone marrow.
46
Taken together, the knock-down of Rab5a and the interference with its wild-type
function by over-expression of a dominant-negative form have diﬀerent eﬀects on
the reconstitution of the various blood cell lineages. This finding is in line with the
observation that these two approaches for abrogating the function of Rab5a results
in diﬀerential phenotypic changes of the endocytic pathway.
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Figure 2.15: Bone marrow cells overexpressing a dominant-negative form of Rab5a
fail to repopulate lethal-irradiated recipient mice. (A, B, C) Blood cell count of
white (WBC) and red blood cells (RBC) as well as platelets (PTL) in recipients of
bone marrow overexpressing Rab5aDN or the empty control vector pMIG. (D, E)
Comparison of total thymus and spleen weights. Each dot represents result from a
single mouse, lines indicate mean values (unpaired t test; n = 3 mice per group; * P
< 0.05; ** P < 0.01).
48
2.3.4 Partial suppression of Vps16 has multiple eﬀects on
blood lineage reconstitution
Vps16 shares 35% identity with the Drosophila Vps16A at the protein level
(http://www.ebi.ac.uk/Tools/sss/ncbiblast). Nevertheless, the mammalian homolog
is functionally involved in the regulation of membrane fusion of endocytic vesicles as
part of multimeric tethering complexes, such as HOPS or CORVET, similar to the
Drosophila protein [Peplowska et al., 2007]. Moreover, the human HOPS complex
was shown to interact with Rab5 and thus regulates endocytosis down-stream of
this small GTPase [Rink et al., 2005]. Knock-down of Vps16A in hemocytes of the
developing fly larvae resulted in a marked increase in the plasmatocyte population.
The relevance of the murine Vps16 in the hematopoietic system was addressed ap-
plying a bone marrow chimeric approach. Lethally-irradiated mice were reconstituted
with Vps16 down-regulated bone marrow cells and the blood cell compartment was
analyzed eight weeks after reconstitution. Flow cytometric analysis showed that the
percentage of various B-cell populations is significantly decreased in the GFP+ sub-
set in the bone marrow, spleen and peripheral blood of Vps16 knock-down chimers.
More precisely, the ratios of B220+, IgM+IgD−, IgM+IgD+, IgM−IgD+ as well as of
CD19+ and CD19+CD25+ B-cells is reduced in Vps16 down-regulated chimeras com-
pared to pMIG control mice. At the same time, a compensatory increase of the same
populations can be observed in the GFP− subset. Moreover, B220+, B220+IgM+,
B220+IgD+ and B220+CD93− B-cells population are as well slightly but significantly
reduced in the spleen of these mice. In the peripheral blood similarly decreased
proportions of B220+ B-cells could be observed (Figure 2.16A). In the T-cell com-
partment, a highly significant reduction in the percentage of CD3+, CD4+ as well
as CD8+ T-cells is present in the peripheral blood of Vps16 knock-down chimeras,
while the ratios of these populations are normal in the thymus and in the spleen
(Figure 2.16B). Interestingly, a reduced percentage of CD4+ T-cells could also be
detected in the peripheral blood of chimeras receiving bone marrow cells with down-
regulated Rab5a, which functions upstream of Vps16 in the endocytic pathway Rink
et al. [2005]. Interestingly, the knock-down of Vps16 further results in a signifi-
cantly higher percentage of c-kit+ precursor cells in the bone marrow. Moreover, the
percentages of GFP+ cells of the myeloid compartment, namely Mac-1+ and Gr-1+
Mac-1+ immature myeloid cells as well as CD11c+ dendritic cells, are significantly
increased in the bone marrow, while the ratio of Gr-1+ granulocytic cells is slightly
but significantly decreased. Of note, these elevated proportions of myeloid cells in
the GFP+ subset were accompanied by a compensatory decrease of the same popula-
tions in the GFP− subset in the Vps16 knock-down chimeras. Furthermore, similarly
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elevated proportions of GFP+ myeloid cells, namely CD11c+ dendritic cells as wells
as Mac-1+ and Gr-1+ Mac-1+ cells could be detected in the spleen of Vps16 knock-
down chimeras compared to pMIG control mice. In the peripheral blood, myeloid
populations are similar among Vps16 knock-down and pMIG control chimeras (Fig-
ure 2.16C). In the natural killer cell department, a minor but significant decrease of
NK1.1+ cells could be observed in the bone marrow while the percentage of this pop-
ulation is significantly increased in the spleen of Vps16 down-regulated bone marrow
chimeras (Figure 2.16D).
In summary, the down-regulation of Vps16 promotes the reconstitution of the
myeloid lineage as well as of CD11c+ dendritic cells, while resulting in a signifi-
cant reduction in the percentage of B-cells. This results indicate a possible shift in
diﬀerentiation in favor of the myeloid lineage.
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Figure 2.16: Comparative flow cytometric analysis of hematopoietic lineages in
mice transplanted with Vps16 shRNA or empty vector (pMIG) infected bone marrow
8 weeks after injection. Percentages of GFP+ (dark grey = pMIG, purple = Vps16)
and GFP- (light grey = pMIG, light blue = Vps16) cells positive for the indicated
lineage markers are represented as columns (mean values ± SEM; n = 3 mice per
group; unpaired two-tailed t test; * P < 0.05; ** P < 0.01; *** P < 0.001). (E)
Distribution of GFP+ cells in the analyzed tissues (n = 3).BM = bone marrow.
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2.3.5 Reconstitution of lethally irradiated mice with Stx7
down-regulated bone marrow cells
The SNARE protein, Syntaxin 7, is another regulator along the endocytic pathway
and mediates homotypic and heterotypic endosome fusion [Nakamura et al., 2000].
Protein alignment analysis revealed an identity of 39% between Mus musculus and
Drosophila melanogaster (http://www.ebi.ac.uk/Tools/sss/ncbiblast). Interestingly,
down-regulation of Stx7 expression in hemocytes in Drosophila larvae caused not
only a severe overproliferation of macrophage-like plasmatocytes, it also induced the
formation of melanotic tumors and an increase of the crystal cell population.
In order to address the function of Stx7 in the hematopoietic system, bone marrow
reconstitution was analyzed in chimeric mice 8 weeks after transplantation. Interest-
ingly, although the bone marrow used for reconstitution of irradiated hosts contained
about 40% infected GFP+ cells, the percentage of GFP+ cells dropped enormously in
all three recipients. The proportion of infected cells was reduced to about 2% in the
bone marrow of these chimeras eight weeks after transplantation (Figure 2.17E). In
contrast, the percentage-wise contribution of the remaining Stx7 knock-down cells
to the major hematopoietic lineages is not impaired in these mice compared to pMIG
control mice. In detail, the knock-down of Stx7 does not aﬀect the B-cell com-
partment neither in the bone marrow and spleen nor in the peripheral blood (Figure
2.17A). Similarly in the T-cell compartment, the percentages of the various T-cell
populations in the GFP+ subset are similar among Stx7 knock-down chimeras and
pMIG control mice (Figure 2.17B). Moreover, the proportion of c-kit+ precursor cells,
myeloid cells as well as CD11c+ dendritic cells in the bone marrow are in the same
range as in pMIG control chimeras. Interestingly, the percentage of Gr-1+ granulo-
cytes is significantly elevated in the spleens of Stx7 knock-down chimeras, while the
peripheral blood harbors normal proportions of this population (Figure 2.17C). The
ratios of erythroblasts as well as NK1.1+ natural killer cells are not aﬀected by the
knock-down of Stx7 (Figure 2.17D).
Taken together, these results indicate that the down-regulation of Stx7 in bone
marrow cells interferes with their ability to repopulate an irradiated recipient mouse,
since a general loss of GFP+ cells can be observed in all three recipient mice. Nev-
ertheless, despite the decreased viability of GFP+ cell in vivo, the percentage-wise
distribution of the remaining GFP+ cells is not overtly aﬀected by the down-regulation
of Stx7.
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Figure 2.17: Flow cytometric analysis of (A) B-cells, (B) T-cells, (C) myeloid cells
and (D) erythroblasts and NK-cells, isolated from bone marrow, spleen, thymus and
peripheral blood of mice injected with Stx7 down-regulated or control bone marrow.
Data are represented as the percentage of GFP+ (dark grey = pMIG, blue = Stx7)
or GFP− (light grey = pMIG, light blue = Stx7) cells positive for the indicated
markers (mean values ± SEM, unpaired t test, n = 3 mice per group, * P < 0.05).
(E) Mean distribution of GFP+ cells in Ssrp1 knock-down (blue) and pMIG control
(grey) chimeras in the analyzed tissues. BM = bone marrow.
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2.3.6 Loss of Vps33a expression in bone marrow cells does
not interfere with their repopulation capacity
The last candidate gene validated in vivo by the chimeric approach is Vps33a,
which is, together with Vps16, part of the multimeric tethering complexes HOPS
or CORVET, that coordinate Rab and SNARE function and provide specificity to
lysosomal or endosomal fusion reactions, respectively [Peplowska et al., 2007]. In
mammals, two homologs of Vps33p, namely Vps33a and Vps33b have been iden-
tified [Huizing et al., 2001]. Nevertheless, comparative genome analysis revealed
that the Drosophila Vps33 gene carnation is closer related to Vps33a than Vps33b
[Gissen et al., 2005]. At the protein level, the murine Vps33a shows 43% identity
to its fruit fly homolog (http://www.ebi.ac.uk/Tools/sss/ncbiblast). The fly screen
showed that the knock-down of the Drosophila homolog carnation in hemocytes of
the developing larvae results in a marked expansion of the plasmatocyte and crystal
cell populations.
In order to reveal its relevance in the mammalian hematopoietic system in vivo,
blood lineage reconstitution was again analyzed in the chimeric transplantation model.
Interestingly, all three bone marrow chimeras receiving the transplant with down-
regulated Vps33a expression, showed an increase in the total percentage of GFP+
cells from 45% prior to injection up to about 80% in the bone marrow and even more
than 90% in the thymus eight weeks after transplantation (Figure 2.18E). How-
ever, the overall increase of Vps33a down-regulated cells does not translate into a
percentage-wise increase of any major blood cell lineage. More precisely, the percent-
ages of various B-cell lineages in the bone marrow, spleen and peripheral blood are
similar among Vps33a knock-down chimeras and pMIG control mice (Figure 2.18A).
Additionally, the knock-down does not aﬀect the T-cell compartment, since there are
no significant diﬀerences in the proportions of any T-lymphocyte population com-
pared to pMIG control mice (Figure 2.18B). The contribution of Vps33a knock-down
cells to the myeloid lineage in the bone marrow and spleen as well as the peripheral
blood is similar to pMIG control mice (Figure 2.18C). Furthermore, the proportion of
NK cells and Ter119+ erythroblast in the bone marrow and the spleen is not impaired
by the knock-down of Vps33a (Figure 2.18D).
In summary, these data indicate that the function of Vps33a might be more redun-
dant in the hematopoietic system than of its binding partner Vps16, probably due to
compensation by its paralog Vps33b [Gissen et al., 2005].
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Figure 2.18: Flow cytometry analysis of mice reconstituted with Vps33 deficient
or control (pMIG) bone marrow 8 weeks after transplantation. Columns show the
percentage of infected cells expressing the indicated markers (mean values ±SEM,
unpaired t test; n = 3 mice per group, *** P < 0.001). Major lineages analyzed in
the stated organs are clustered in subsequent panels: (A) B-cells, (B) T-cells, (C)
myeloid cells and (D) erythroblasts & natural killer cells. (E) Mean distribution of
GFP+ cells in Vps33a knock-down (purple) and pMIG control (grey) chimeras in the
analyzed tissues. BM = bone marrow.
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2.4 Generation and characterization of a transgenic
mouse line overexpressing a dominant-negative
form of Rab5a
Considering the strong phenotype observed in Drosophila lacking Rab5 expression
in plasmatocytes, as well as the interesting functionality of the protein as a small
regulatory GTPase involved in endocytosis, we decided to generate a transgenic
mouse line conditionally overexpressing the dominant-negative mutant of Rab5a,
to study its function in hematopoiesis more precisely. Therefore, we introduced the
same serine to asparagine substitution at amino acid residue 34 (S34N) by PCR based
site-directed mutagenesis as described previously [Li and Stahl, 1993]. The mutated
Rab5a coding region was subcloned into the pIRES-EGFP2 vector (Figure 2.19A),
then excised together with the IRES-EGFP sequence and inserted into the pCCALL2
vector [Novak et al., 2000] (Figure 2.19B). Following Cre mediated recombination,
the chicken ß-actin promoter and the CMV enhancer control high expression of the
transgene together with the GFP reporter via the internal ribosome entry site (IRES).
A B
Figure 2.19: Generation of Rab5aDN transgenic mice. (A) Vector map of pIRES2-
EGFP used for subcloning of the Rab5aDN construct to add the IRES-EGFP se-
quence. (B) Schematic of the linearized pCALL2-Rab5aDN-IRES-EGFP vector used
for pronuclear injection.
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In total 5 founder lines harboring the transgene were generated by pronuclear
injection, hereafter referred to as Rab5aDN lines α, β, γ, δ and ε. The presence of
the transgene in the chromosomal DNA of the founder animals was confirmed by
PCR (Figure 2.20A). In order to analyze transgene expression in the oﬀspring, we
took advantage of lacZ/neomycin fusion gene (ßgeo) [Friedrich and Soriano, 1991]
that is inserted in the stop cassette between the two LoxP sites. Thus, prior to
Cre-mediated recombination the animals express the enzyme ß-galactosidase, which
is able to hydrolyse X-Gal to Galactose and a detectable blue chromophore [Friedrich
and Soriano, 1991]. The two male founder mice α and β were crossed to C57BL/6
females and LacZ staining was performed on frozen sections of the embryos isolated
on embryonic day E13.5. Unfortunately, only poor LacZ expression could be detected
in the striated muscle of the heart, the lung and the spinal cord in the α line and in
muscle and connective tissue in the ß line (Figure 2.20B).
Since the LacZ assay is not very sensitive and high expression levels of ß-galactosidase
are needed, the mRNA abundance of the transgene was determined by RT-PCR. For
this purpose, the α, β and γ founder lines were crossed to Vav-iCre mice, that specif-
ically deletes the stop cassette and induces transgene expression in hematopoietic
tissues in the oﬀspring [de Boer et al., 2003]. The resulting mice from this cross,
that were either positive for the dominant-negative Rab5a transgene (DN+) or double
positive for Rab5aDN and cre (DN+Cre+), were sacrificed at 6 weeks of age and the
mRNA expression levels of neomycin (Neo) were analyzed in the bone marrow, spleen
and thymus. Thus, only mice carrying the transgene, but not Cre, should be positive
for neomycin expression since the ßgeo cassette is lost upon recombination. In the
ß line, no expression of neomycin could be detected in any of the analyzed organs.
Additionally, the expression in the α line seems to be rather unspecific, since the first
two animals express neomycin in the bone marrow, but not in the spleen or thymus,
whereas the third DN+mouse shows Neo expression in the thymus but not in the
other two tissues. However, the oﬀspring of the γ founder line shows strong expres-
sion of neomycin in the bone marrow as well as the thymus in the mouse harboring
only the transgene. Importantly, the abundance of neomycin mRNA is significantly
reduced in γ mice positive for cre (Figure 2.21).
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Figure 2.20: Characterization of Rab5aDN transgenic lines. (A) Presence of the
transgene in genomic DNA of the founder animals was verified by PCR using the
following primers: Neo (1), the cloning primers Rab5DN1 and Rab5DN4 (2) and the
qPCR primers mRab5a_for and mRab5a_rev (3). For primer sequences see Material
and Methods. (B) Male founders of the α and β line were crossed to wildtype
C57BL/6 females and the tissue distribution of transgene expression was analyzed
by LacZ staining of frozen sections of whole embryos at day E13.5. Arrows indicate
areas positive for ß-galactosidase expression.
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Taken together, the Rab5aDN transgenic γ line seems to be a promising candidate
for further evaluation of the function of Rab5a in the hematopoietic system. We are
currently crossing this line to Vav-iCre mice, which leads to conditional overexpression
of the dominant-negative mutant in all hematopoietic cells. Afterwards, we will
determine if Vav-γRab5aDN mice harbor any hematological abnormalities. Moreover,
we hope that these mice will allow us to answer the open questions raised by the
results of the Rab5a knock-down and dominant-negative mutant overexpressing bone
marrow chimeras.
59
Figure 2.21: Expression of the transgene in the oﬀspring of the α, β and γ lines was
determined in the bone marrow (BM), spleen (SP) and thymus (TH) of individual
mice by RT-PCR using Neo primers. Total RNA was isolated and converted into
cDNA (D). Untreated RNA (R) was used to test for contamination of genomic
DNA.
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2.5 Papilin
The knock-down of Papilin in Drosophila hemocytes caused one of the most promi-
nent phenotypes in the hematopoiesis screen, namely marked overproliferation of
plasmatocytes and melanotic tumor formation in the fly larvae. Papilin is a large ex-
tracellular matrix (ECM) glycoprotein [Campbell et al., 1987] with homologs found
in nematodes, mice and humans. The Papilin found in Mus musculus shows a pro-
tein identity of 39% to its Drosophila homolog (http://www.ebi.ac.uk/Tools/sss/
ncbiblast). Functionally, Papilin is suggested to play a regulatory role in develop-
ment, organogenesis and angiogenesis by modulating the activity of ADAMTS met-
alloproteinases [Kramerova et al., 2003]. Since, the precise function of papilin in
development is still elusive and more importantly its possible role in the hematopoi-
etic system has never been addressed in mammals so far, a conditional knock-out
mouse was generated [Elling et al., unpublished]. Papilin complete knock-out mice
(Papilin KO) are viable and do not display any obvious defects.
In order to test whether the absence of Papilin expression causes any phenotypic
eﬀects in the hematopoietic system in adult mice, the major blood cell lineages of 10
week old Papilin KO as well as wildtype littermates were analyzed by flow cytometry.
The relative weight of the spleen appears to be slightly increased in Papilin KO mice
compared to wild-type or heterozygous littermates, although the diﬀerence is not
significant. The relative thymus weight is similar among mutant and wildtype mice
(Figure 2.22A). Interestingly, the blood cell count revealed a significantly decreased
percentage as well as overall number of granulocytes in the peripheral blood of Papilin
KO mice (Figure 2.22B, C). The flow cytometric analysis did not show any major
diﬀerences of the blood cell populations in Papilin KO mice compared to wild-type or
heterozygous littermates. A minor increase in the total percentage of CD19+ B-cells
can be observed in the bone marrow as well as the lymph nodes (Figure 2.22D).
In the myeloid compartment, a slight decrease in the percentage of c-kit+ precursor
cells was detected (Figure 2.22E). Of note, one of the three Papilin KO mice showed
a more than 4-fold increase in the percentage of Gr-1+ granulocytic cells in the
bone marrow. Taken together, these preliminary results indicate a possible role for
Papilin in granulocyte diﬀerentiation or homeostasis. Further analysis, especially of
older mice, which might show a more prominent phenotype, will be necessary to
specifically rule out the relevance of Papilin in the hematopoietic compartment.
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Figure 2.22: Analysis of the hematopoietic compartment in Papilin (Ppn) KO mice.
(A) Relative weight of spleen and thymus represented as percentage of body weight
of 10-week old Papilin KO mice as well as littermate controls (wildtype and heterozy-
gous). (B, C) Blood count of lymphocytes (LYM), monocytes (MO) and granulocytes
(GRA) in Papilin KO mice and littermate controls. Data are shown as cell number
per mm3 (C) or percentage (D) of peripheral blood. (D, E) Major hematopoietic
populations in the bone marrow (BM), spleen, lymph node (LN) and thymus were
analyzed by flow cytometry. Data are shown as percentage of total viable cells posi-
tive for the indicated marker. Data are shown as mean ± SEM (t test; n = 3 mice
per group; * P < 0.05; ns = not significant).
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Contributions
All the experiments shown here were done by myself, except the following: Ulrich
Elling conducted the fly screen and generated the conditional Papilin knock-out mice.
Moreover, he supervised the selection of the candidate genes and helped with the
isolation of bone marrow cells for the generation of the bone marrow chimeras and
dissection of chimeras for flow cytometric analysis.
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3 Discussion
The genes analyzed here for their role in the hematopoietic system were initially
identified in a genome-wide RNAi screen conducted to determine novel regulators of
blood cell development as well as homeostasis that are conserved among flies and
mammals. The down-regulation of the candidate genes in the fly larvae by RNA in-
terference resulted in fruit fly “leukemia” characterized by massive overproliferation
of plasmatocytes as well as the formation of melanotic tumors. Seven of the iden-
tified potential tumor suppressor genes were further validated for their importance
in blood cell formation in mammals. Functionally, two of the candidates, namely
Symplekin and Ssrp1, are implicated in transcriptional regulation, while four other
selected genes, specifically Rab5a, Stx7, Vps16 and Vps33a, regulate various cru-
cial steps along the endocytic pathway. The last candidate, Papilin, is proposed to
act as a metalloproteinase inhibitor, which suggests a possible association to tumor
progression and metastasis.
The generation of bone marrow chimeras allowed us to determine whether bone
marrow cells with down-regulated expression of the selected genes are still capable
to reconstitute a lethally irradiated host and to what extent these cells contribute to
hematopoietic cell lineages. We could show that the down-regulation of two out of six
genes, namely Symplekin and Vps16, preferentially promotes the repopulation of the
myeloid lineage, leading to an increased percentage of immature or mature myeloid
cells in the bone marrow and spleen. Interestingly, knock-down of these two genes was
also associated with an increased contribution to the c-kit+ precursor compartment.
On the other hand, down-regulation of Vps16 and Sympk, additionally caused a
decrease in the proportion of B-cells in the bone marrow, spleen and peripheral blood,
while in Rab5a knock-down chimeras B220+ cells were only reduced in the peripheral
blood. At the same time, the down-regulation of these two candidate genes had
a negative eﬀect on reconstitution of the T-cell compartment, demonstrated by a
reduced representation of peripheral T-cells in the blood of Sympk and Vps16 knock-
down chimeras. In contrast to this under-representation of various GFP+ B- and
T-lymphocyte lineages in these chimeras, the percentage of the third lymphocyte
population, namely natural killer cells, is elevated in the spleen compared to pMIG
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control mice. On the other hand, the percentage of NK1.1+ natural killer cells
was reduced in the bone marrow of Vps16 knock-down chimeras. Moreover, these
chimeras harbored an increased percentage of CD11c+ in the bone marrow and the
spleen. Together, these results indicate that the knock-down of Symplekin and Vps16
promotes an early lineage shift in favor of myeloid cells. Furthermore, the expansion
of c-kit+ cells in Sympk and Vps16 chimeric mice was correlated with an increase in
the proportion of immature or mature myeloid cells, arguing against a diﬀerentiation
block as explanation for the increased c-kit+ precursor population.
Interestingly, the recipient mice reconstituted with Rab5a down-regulated bone
marrow cells, showed a similar but much milder reconstitution phenotype than the
Symplekin and Vps16 knock-down chimeras. More precisely, the knock-down of
Rab5a in the bone marrow transplant resulted in a significantly decreased percentage
of B220+ B-cells and CD4+ T-cells in the peripheral blood of recipient mice, while
the proportion of NK1.1+ natural killer cells was elevated in the spleen. Moreover,
immature myeloid cells were slightly increased in the spleens of these chimeras. How-
ever, these results could only be reproduced to some extent in chimeras harboring
bone marrow cells that over-express a dominant-negative mutant form of Rab5a.
More precisely, these chimeras displayed a decreased percentage of CD4+ T-cells in
the spleen, but not in the peripheral blood. Moreover, unlike Rab5a knock-down
chimeras Rab5a mutant mice harbored a increased percentage of immature myeloid
cells in the bone marrow and not in the spleen. Furthermore, the over-expression of
dominant-negative Rab5a had no negative eﬀect on the repopulation of the B-cell
compartment. An explanation for these findings might be that these two approaches
to interfere with the function of Rab5a have diﬀerential eﬀects on receptor-mediated
endocytosis. The overexpression of the dominant-negative mutant leads to an accu-
mulation of small vesicles and inhibits endocytosis [Stenmark et al., 1994], while the
knock-down of Rab5a alone seems not to interfere with receptor-mediated endocy-
tosis [Huang et al., 2004]. Thus, these data indicate that the phenotypic changes
observed in Rab5a knock-down chimeras, especially the negative eﬀect on the B-cell
compartment, might be independent of interference with receptor-mediated endocy-
tosis.
Interestingly, the most prominent changes in reconstitution were observed in the
bone marrow chimeras harboring the least eﬃcient gene down-regulation, particularly
in the case of Vps16 and Symplekin. A recent study applying a similar chimeric
approach to identify novel tumor suppressor genes by RNA interference, showed that
there is an inverse correlation between shRNA potency and proliferative advantage,
due to a negative selection against cells harboring a potent shRNAs in vivo [Bric
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et al., 2009]. Thus, bone marrow cells harboring a moderate knock-down might be
more likely to promote phenotypical changes. Importantly, this eﬀect could as well
explain the massive decrease of GFP+ cells in the recipients reconstituted with Stx7
down-regulated bone marrow, since the shRNA against Stx7 appears to confer one
of the most potent knock-downs in vivo.
Strikingly, all lineages showing an increased percentage upon knock-down of Sym-
plekin, Rab5a or Vps16 belong to innate branch of the immune system, namely
myeloid cells or NK-cells. This finding could be explained by the restriction of the
Drosophila immune system to innate immunity [Reumer et al., 2010]. These results
underline the close relationship of fly plasmatocytes to the mammalian myeloid lin-
eage and support an evolutionary link between natural killer cells and fly hemocytes.
Nevertheless, we were not successful in recapitulating the complete severe phe-
notype observed in fly larvae, namely a myeloproliferative disorder (MPD) or even
leukemia in mice. Moreover, the knock-down of three of the candidate genes, namely
Ssrp1, Stx7, and Vps33a, in the bone marrow did not reveal any marked phenotypi-
cal changes in any of the hematopoietic lineages. This is not surprising considering
that for instance acute myeloid leukemias develop as a consequence of at least two
types of genetic alterations: One mutation that interferes with normal hematopoietic
diﬀerentiation and a second hit that confers a proliferative and/or survival advan-
tage [Gilliland et al., 2004; Schindler et al., 2009; Mercher et al., 2009]. Thus, mice
harboring only the chromosomal translocation frequently found in human leukemias,
mainly develop myeloproliferative disease with a long latency and rare leukemia with
low penetrance after six months of age [Ono et al., 2005]. Importantly, introduction
of an additional oncogenic lesion promotes full recapitulation of the leukemic phe-
notype observed in humans [Zuber et al., 2009]. Thus, testing the relevance of the
identified genes in an already cancer-prone background, such as the oncogenic Eµ-
myc lymphoma mouse model or the AML1/ETO fusion oncoprotein driven myeloid
leukemia model [Adams et al., 1985; Yuan et al., 2001], might allow us to determine
whether the candidates would promote tumorigenesis. Moreover, the introduction
of an internal control by co-transplanting wild-type bone marrow cells expressing a
diﬀerent fluorescent protein such as RFP or dsRed Zuber et al. [2009] or the use
of congenic donor and recipient mice, such as CD45.1 and CD45.2 or Thy1.1 and
Thy1.2, would allow us to compare only the transplanted hematopoietic cells with
down-regulated gene function with wild-type cells in the same mouse. Additionally,
this approach would help enable us to exclude secondary eﬀects caused by incom-
plete deprivation of hematopoietic cells in the recipient and possible antiviral immune
responses against the transplant.
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Finally, we could detect a significant reduction of peripheral granulocytes in Papilin
KO mice as well as a massive increase of Gr-1+ granulocytes in the bone marrow of
one of these mice. These data suggest that mature granulocytes might accumulate
in the bone marrow leading to a general decrease in the circulation. We also found
a decreased percentage of c-kit+ precursor cells in the bone marrow, which could
as well explain the reduction of granulocytes in the peripheral blood. Notably, the
blood count does not distinguish between mature or immature cells, thus it would
be interesting to determine more precisely by flow cytometry which population is
aﬀected in the peripheral blood. Taken together, these preliminary results indicate
that Papilin might indeed contribute to either myeloid cell diﬀerentiation or migration.
Further analysis of additional mice will be necessary to elucidate the eﬀects of Papilin
down-regulation on the various blood cell compartments.
In summary, the present study indicates that the conserved factors identified
to regulate proliferation and homeostasis of blood cells in the fruit fly Drosophila
melanogaster, to some degree also play a role in hematopoiesis in mice.
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4 Material and Methods
4.1 Antibodies
For flow cytometric analysis, the following antibodies from were used: PE-conjugated
Ter119 (Pharmingen #09085B); PE-conjugated CD4 (Pharmingen #553049); PE-
conjugated IgD (Pharmingen #558597); APC-conjugated CD117/c-kit (Pharmin-
gen #01909A); APC-conjugated CD11c (Pharmingen #550261); APC-conjugated
CD3 (Pharmingen #01089A); biotinylated IgM (Pharmingen #02082D); biotiny-
lated NK1.1 (Pharmingen #01292D); biotinylated CD25 (Pharmingen #01092D);
PE-Cy5-conjugated CD19 (Pharmingen #551001); PE-Cy5-conjugated Gr-1 (eBio-
science #15-5931-82); PE-Cy5-conjugated CD44 (Pharmingen #553135); PE-Cy7-
conjugated B220 (eBioscience #25-0452-82); PE-Cy7-conjugated CD93 (eBioscience
#25-5892-82); PE-Cy7-conjugated CD8α (eBioscience #25-0081-81); PE-Cy7-conju-
gated CD11b/Mac-1 (Pharmingen #552850); APC-Cy7-conjugated B220 (eBio-
science #10-0452-81); APC-Cy7-conjugated CD25 (eBioscience #10-0251-81); APC-
Cy7-conju-gated CD8α (Pharmingen #557654); and streptavidin-PacBlue (Invitro-
gen #S11222).
4.2 Viral vector and cloning
Three specific small hairpin RNAs (shRNAs) were designed for each gene using the
online algorithm “RNAi Oligo Retriever” at RNAi Central (http://katahdin.cshl.org:
9331/homepage/siRNA/RNAi.cgi?type=shRNA). The hairpins were generated by
PCR amplification of a 97 basepair long single stranded oligonucleotide (Sigma,
HPLC purified) using the common primers miR30 FWD and miR30 REV (Table 4.1)
and were ligated into the LMP microRNA-adapted retroviral vector (Open Biosys-
tems, Huntsville, AL).
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Table 4.1: Sequences of PCR primers used for cloning of shRNAs and of the single-
stranded oligonucleotides used to amplify the shRNAs.
Oligo name Sequence (5’ - 3’)
miR30 FWD CAGAAGGCTCGAGAAGGTATATTGCTGTTGACAG
TGAGCG
miR30 REV CTAAAGTAGCCCCTTGAATTCCGAGGCAGTAGGC
A
mSsrp1_shOligo1 TGCTGTTGACAGTGAGCGACCTCGGGATCTGATG
AATAAATAGTGAAGCCACAGATGTATTTATTCAT
CAGATCCCGAGGCTGCCTACTGCCTCGGA
mSsrp1_shOligo2 TGCTGTTGACAGTGAGCGCGCCCAGAATGTTCTG
TCAAAGTAGTGAAGCCACAGATGTACTTTGACAG
AACATTCTGGGCATGCCTACTGCCTCGGA
mSsrp1_shOligo3 TGCTGTTGACAGTGAGCGCGGGCTTAAACTGCTC
ACAAAGTAGTGAAGCCACAGATGTACTTTGTGAG
CAGTTTAAGCCCATGCCTACTGCCTCGGA
mRab5a_shOligo1 TGCTGTTGACAGTGAGCGCCCTAATATTGTGATA
GCTTTGTAGTGAAGCCACAGATGTACAAAGCTAT
CACAATATTAGGATGCCTACTGCCTCGGA
mRab5a_shOligo2 TGCTGTTGACAGTGAGCGCTGACAACAGCTTATT
ATTTATTAGTGAAGCCACAGATGTAATAAATAAT
AAGCTGTTGTCATTGCCTACTGCCTCGGA
mRab5a_shOligo3 TGCTGTTGACAGTGAGCGCGGCAAGCAAGTCCTA
ATATTGTAGTGAAGCCACAGATGTACAATATTAG
GACTTGCTTGCCTTGCCTACTGCCTCGGA
mStx7_shOligo1 TGCTGTTGACAGTGAGCGCGCTGATATTATGGAC
ATTAATTAGTGAAGCCACAGATGTAATTAATGTC
CATAATATCAGCTTGCCTACTGCCTCGGA
mStx7_shOligo2 TGCTGTTGACAGTGAGCGCTGAGAGAGAGTCTTC
AATCAGTAGTGAAGCCACAGATGTACTGATTGAA
GACTCTCTCTCATTGCCTACTGCCTCGGA
mStx7_shOligo3 TGCTGTTGACAGTGAGCGATCCGACTCATTCATG
AGAGAGTAGTGAAGCCACAGATGTACTCTCTCAT
GAATGAGTCGGAGTGCCTACTGCCTCGGA
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mVps16_shOligo1 TGCTGTTGACAGTGAGCGCACTGAGGAACTGTTG
GAGAAATAGTGAAGCCACAGATGTATTTCTCCAA
CAGTTCCTCAGTATGCCTACTGCCTCGGA
mVps16_shOligo2 TGCTGTTGACAGTGAGCGAGCCATTAAGCTGCTG
GAGTATTAGTGAAGCCACAGATGTAATACTCCAG
CAGCTTAATGGCCTGCCTACTGCCTCGGA
mVps16_shOligo3 TGCTGTTGACAGTGAGCGCACAGTGTTGCTGCAC
CTAAAGTAGTGAAGCCACAGATGTACTTTAGGTG
CAGCAACACTGTATGCCTACTGCCTCGGA
mSympk_shOligo1 TGCTGTTGACAGTGAGCGCGCTGAGGAGGTCATG
GAATACTAGTGAAGCCACAGATGTAGTATTCCAT
GACCTCCTCAGCTTGCCTACTGCCTCGGA
mSympk_shOligo2 TGCTGTTGACAGTGAGCGCCGAGAGTATGTGGAG
AAATTTTAGTGAAGCCACAGATGTAAAATTTCTC
CACATACTCTCGATGCCTACTGCCTCGGA
mSympk_shOligo3 TGCTGTTGACAGTGAGCGATCAGGCACTCTGGAC
AAATATTAGTGAAGCCACAGATGTAATATTTGTC
CAGAGTGCCTGAGTGCCTACTGCCTCGGA
mVps33a_shOligo1 TGCTGTTGACAGTGAGCGAACTGATAAGGTCAAC
AGTTACTAGTGAAGCCACAGATGTAGTAACTGTT
GACCTTATCAGTGTGCCTACTGCCTCGGA
mVps33a_shOligo2 TGCTGTTGACAGTGAGCGCGCTGAGAATGTACTC
AGTGAGTAGTGAAGCCACAGATGTACTCACTGAG
TACATTCTCAGCATGCCTACTGCCTCGGA
mVps33a_shOligo3 TGCTGTTGACAGTGAGCGCGCACATACTGACCTT
GAACAATAGTGAAGCCACAGATGTATTGTTCAAG
GTCAGTATGTGCTTGCCTACTGCCTCGGA
4.3 Packaging cell line and retroviral production
Ecotropic Platinum-E (Plat-E) retroviral packaging cells (THP Medical Products,
Vienna, Austria) were grown under standard conditions (37°C, 5 CO2) in growth
medium (DMEM, 10% FCS, 100 U/ml penicillin, 100 ￿g/ml streptomycin) containing
10 ￿g/ml blasticidin and 1 ￿g/ml puromycin. One day before transfection, 6x106
cells were plated onto a 10cm dish in growth medium without antibiotics. After 24
hours cell were transfected with 9 ￿g DNA using Fugene 6 (Roche Diagnostics GmbH,
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Vienna, Austria) according to manufacturers protocol. Transfection eﬃciency was
analyzed by flow cytometry for GFP-expressing cells. Viral particles in the supernatant
were collected 36h, 48h, 56h and 64h after transfection and sterile-filtered through
a 45 ￿m syringe filter.
4.4 Bone Marrow Chimeras
Male 6 to 8 weeks old C57BL/6J wildtype mice were injected with 2.5mg 5-fluorouracil
in PBS intraperitoneally (i.p.). Four days after injection, bone marrow cells were iso-
lated from the fore- and hindlimbs by flushing the long bones (humerus, tibia and
femur) with a syringe with PBS containing 4% FCS. After red blood cell lysis with
ACK buﬀer, cells were prestimulated overnight in growth medium (DMEM, 10%
FCS, 100 U/ml penicillin, 100 ￿g/ml streptomycin, 1% L-Glutamine) supplemented
with 50 ng/ml recombinant mouse IL-6 (rmIL-6) and 50 ng/ml rmSCF, as well as
20 ng/ml rmIL-3 (PeproTech Austria, Vienna) at a density of 1x106 cells/ml. For
the first infection, 1x107 cells were seeded onto RetroNectin-coated plates (Takara,
Japan), that were preincubated with viral supernatant for 4 hours at 37°C, in cytokine
containing growth medium. The second, third and fourth infection was performed
after 8h, 16h or 48h, respectively, by adding fresh sterile-filtered viral supernatant
supplemented with the cytokine mix on top of the cells. 12h to 16h after the last
infection, bone marrow cells were washed three times with PBS, counted and infec-
tion eﬃciency was determined by flow cytometry. Subsequently, 1.2x106 cells were
transplanted into lethally gamma-irradiated (10Gy), 6 week old C57BL/6J mice via
tail-vein injection (3 mice per genotype). After injection, mice were treated with
10mg/ml Enrofloxacin (Baytril, Bayer) in the drinking water for 7 days, to prevent
infection. Six to eight weeks after reconstitution, mice were sacrificed and the major
blood cell lineages were analyzed by flow cytometry.
4.5 Flow Cytometry
Bone marrow chimeras were sacrificed by carbon dioxide asphyxiation and peripheral
blood, bone marrow, spleen and thymus were isolated. After red blood cell lysis,
single cell suspensions were incubated for 15 min with 2.5 ￿g/ml mouse Fc block
(PD Pharmingen) in PBS containing 4% FCS on ice. Cells were washed once, 200
￿l primary antibody mix per sample was added and incubated on ice for 30 min in
the dark. First antibody was washed out, followed by incubation with secondary
antibody for 30 min at 4°C covered from light. Stained cells were washed three
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times and samples were analyzed with a PD LSRFortessa cell analyzer using the BD
FACSDiva software.
4.6 Generation of a dominant-negative mouse line
The full length murine Rab5a was amplified and muted by two step PCR-based
mutagenesis using the primers Rab5DN_1, Rab5DN_2, Rab5DN_3 and Rab5DN_4
(Table 4.2) and inserted into the pIRES2-EGFP expression vector. The coding region
of the Rab5aDN transgene was then excised together with the IRES-EGFP sequence
and ligated into the pCALL2 vector. Insertion of the correct sequence was confirmed
by sequencing. The vector was then linearized, the DNA was gel purified using the
Elutrap Electroelution System (Whatman) and injected into male pronuclei of single-
cell (FVB/N) embryos. Viable eggs were subsequently transferred to pseudo-pregnant
B6CBAF1 recipients.
4.7 LacZ staining
Male six week old founder mice of the Rab5DN transgenic line α and β were crossed
to wildtype C57BL/6 females. Whole embryos were isolated at day E13.5 of preg-
nancy and fixed in 2% paraformaldehyde in 1xPBS for 2h on ice. Embryos were
cryoprotected in 20% sucrose in 1x PBS overnight at 4°C and embedded into Tissue-
Tek OCT (Sakura) over dry ice. Blocks were cryosectioned at 10 ￿m, placed onto
adhesion microscope slides (Super Frost Ultra Plus, Menzel), and dried for 2 h at
room temperature before storage at -20°C. After re-hydration in 1xPBS , slides were
stained in Bluo-Gal staining solution (1.0 mg/ml X-gal, 20 mM potassium ferro-
cyanide (K4(Fe(CN)6)), and 20 mM potassium ferricyanide (K3(Fe(CN)6)), 2 mM
MgCl2, 0.01% sodium deoxycholate, 0.02% Nonidet-P40 in 1xPBS) overnight at
37°C, protected from light. Afterwards slides were rinsed in PBS, counterstained
with eosin and mounted with coverslips. Slides were analyzed with a Zeiss Axioskop
2 Plus upright microscope.
4.8 qRT-PCR
Total RNA was extracted from bone marrow cells, splenocytes, thymocytes or BaF/3
cells, respectively, using the RNeasy Mini Kit (Qiagen, Kat.No.: 74104). 3,3 ￿g of
total RNA was converted to cDNA using Ready to go Beads (GE Healthcare, Cat.
No. 27-9264-01) and random hexamers as primer. For quantitative (q)RT-PCR
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analysis, 10ng of cDNA (diluted 1:10 with dH2O) was mixed with iQ SYBR Green
Real-Time PCR Supermix (BioRad) and the primers depicted in Table 4.2. Samples
were analyzed as duplicates in a BioRad iG5 Multicolor real-time PCR Detection
System.
4.9 Blood count
Mice were sacrificed and 20 ￿l of freshly collected blood was mixed with 5 ￿l of 0.5M
EDTA (pH 8.0) to prevent blood clotting. Samples were analyzed twice with a Scil
Vet abc animal blood counter.
74
Table 4.2: Sequences of used PCR primers and of the single-stranded oligonu-
cleotides used to amplify the shRNAs.
Oligo name Sequence (5’ - 3’)
mVps16_for ACTGTTACACTGCGAACTGG
mVps16_rev CTCAGTAGAGCAATGGGACC
mStx7NEW_for CGGAAGTTCACGTTCAACAG
mStx7NEW_rev CCTTTCAGTCCCCATACGAT
NEWmVps33a_for CGTGTTTGATAACCTCTTGCTG
NEWmVps33a_rev TCTTGGGTGCAAACTTCTCTG
mSsrp1_for GAAACGGGAACAGCTCAAAAG
mSsrp1_rev GCATTAAGCCACAGCATGTAC
mRab5a_for TGGTCAAGAACGGTATCATAGC
mRab5a_rev GCCTTTGAAGTTCTTTAACCCAG
mSympk_for CAGCTTCGAGAGTATGTGGAG
mSympk_rev TGCTTCACTGTTTCCTCTGTC
mActb_F CTTTGCAGCTCCTTCGTTG
mActb_R CGATGGAGGGGAATACAGC
Rab5DN_1(BglII)_F GAAGATCTGGACTTCTTTAAAATTTGGACATGG
Rab5DN_2(34N)_R CGAAGAACCAGGCTATTTTTGCCAACAGCAG
Rab5DN_3(34N)_F CTGCTGTTGGCAAAAATAGCCTGGTTCTTCG
Rab5DN_4(EcoRI)_R2 GGAATTCCGGAGCTCAGTTACTACAACACTGG
Neo_forward GTGGAGAGGCTATTCGGCTATGACT
Neo_reverse CTTGAGCCTGGCGAACAGTTCGGCT
75
76
5 Acknowledgements
Upon finishing this thesis, I would like to use this opportunity to thank all the people
that helped along the way during my studies and enabled me to finish this thesis.
First, I want to thank Josef Penninger for oﬀering my the opportunity to work
on this interesting project in his laboratory and for thoroughly correcting this thesis.
Moreover, special thanks goes to Ulrich Elling, who supervised my work and taught
me many new things. I also want to thank all the members of the Penninger group
for turning this year into a unique experience and always being helpful when needed.
Without any doubt, my endless gratefulness goes to my family who constantly
supported me. First, I want to thank my sister Anna for having an open ear for my
troubles and always oﬀering good advice. Moreover, I want to thank my uncle Rudi
for being like a father, when I needed one, and my aunt Christa, for always giving
me the feeling that she is there for me no matter what happens. I am also grateful
that my “Omi” is still able to supply me with the best “Kärntner Nudel” and always
showing me that she is proud of her granddaughter. Last, I want to thank my father
for his financial support thereby enabling me to study in Vienna.
At this point, I also want to especially thank Geri, who became my best friend in
the course of studies. I am grateful because he showed me how to take life easier
and because he believed in me in moments when I got hopeless. Finally, I also want
to thank all my other friends for helping me to relax and get my mind of studying
and work, while spending legendary nights out with me.
77
78
Bibliography
Adams, J., Harris, A., Pinkert, C., Corcoran, L., Alexander, W., Cory, S., Palmiter, R.,
and Brinster, R. (1985). The c-myc oncogene driven by immunoglobulin enhancers
induces lymphoid malignancy in transgenic mice. Nature, 318:533–538.
Adams, M., Celniker, S., Holt, R., Evans, C., Gocayne, J., Amanatides, P., Scherer,
S., Li, P., Hoskins, R., and Galle, R. (2000). The genome sequence of drosophila
melanogaster. Science, 287(5461):2185.
Agaisse, H., Petersen, U., Boutros, M., Mathey-Prevot, B., and Perrimon, N. (2003).
Signaling role of hemocytes in drosophila jak/stat-dependent response to septic
injury. Developmental cell, 5(3):441–450.
Alfonso, T. B. and Jones, B. W. (2002). gcm2 promotes glial cell diﬀerentiation
and is required with glial cells missing for macrophage development in drosophila.
Developmental Biology, 248(2):369–83.
Antonin, W., Holroyd, C., Fasshauer, D., Pabst, S., von Mollard, G., and Jahn,
R. (2000). A snare complex mediating fusion of late endosomes defines conserved
properties of snare structure and function. The EMBO Journal, 19(23):6453–6464.
Barnard, D., Ryan, K., Manley, J., and Richter, J. (2004). Symplekin and xgld-2 are
required for cpeb-mediated cytoplasmic polyadenylation. Cell, 119(5):641–651.
Barton, G. M. and Kagan, J. C. (2009). A cell biological view of toll-like receptor
function: regulation through compartmentalization. Nature Reviews Immunology,
9(8):535–42.
Belotserkovskaya, R., Oh, S., Bondarenko, V. A., Orphanides, G., Studitsky, V. M.,
and Reinberg, D. (2003). Fact facilitates transcription-dependent nucleosome
alteration. Science, 301:1090–1093.
Belotserkovskaya, R. and Reinberg, D. (2004). Facts about fact and transcript
elongation through chromatin. Current Opinion in Genetics & Current Opinion in
Genetics & Development, (14):139–146.
79
Birk, D. M., Barbato, J., Mureebe, L., and Chaer, R. A. (2008). Current insights
on the biology and clinical aspects of vegf regulation. Vasc Endovascular Surg,
42(6):517–30.
Biswas, D., Imbalzano, A., Eriksson, P., Yu, Y., and Stillman, D. (2004). Role for
nhp6, gcn5, and the swi/snf complex in stimulating formation of the tata-binding
protein-tfiia-dna complex. Molecular and cellular biology, 24(18):8312.
Bresnick, E., Lee, H., Fujiwara, T., Johnson, K., and Keles, S. (2010). Gata switches
as developmental drivers. Journal of Biological Chemistry, 285(41):31087.
Bric, A., Miething, C., Bialucha, C. U., Scuoppo, C., Zender, L., Krasnitz, A., Xuan,
Z., Zuber, J., Wigler, M., Hicks, J., Mccombie, R. W., Hemann, M. T., Hannon,
G. J., Powers, S., and Lowe, S. W. (2009). Functional identification of tumor-
suppressor genes through an in vivo rna interference screen in a mouse lymphoma
model. Cancer Cell, 16(4):324–335.
Bucci, C., Lütcke, A., Steele-Mortimer, O., Olkkonen, V., Dupree, P., Chiariello,
M., Bruni, C., Simons, K., and Zerial, M. (1995). Co-operative regulation of
endocytosis by three rab5 isoforms. FEBS letters, 366(1):65–71.
Buchert, M., Darido, C., Lagerqvist, E., Sedello, A., Cazevieille, C., Buchholz, F.,
Bourgaux, J., Pannequin, J., Joubert, D., and Hollande, F. (2009). The sym-
plekin/zonab complex inhibits intestinal cell diﬀerentiation by the repression of
aml1/runx1. Gastroenterology, 137(1):156–164.
Calvo, O. and Manley, J. L. (2003). Strange bedfellows: polyadenylation factors at
the promoter. Genes & Development, 17(11):1321–7.
Campbell, A., Fessler, L., Salo, T., and Fessler, J. (1987). Papilin: a drosophila
proteoglycan-like sulfated glycoprotein from basement membranes. Journal of Bi-
ological Chemistry, 262(36):17605.
Cao, S., Bendall, H., Hicks, G., Nashabi, A., Sakano, H., Shinkai, Y., Gariglio, M.,
Oltz, E., and Ruley, H. (2003). The high-mobility-group box protein ssrp1/t160 is
essential for cell viability in day 3.5 mouse embryos. Molecular and cellular biology,
23(15):5301.
Cho, N., Keyes, L., Johnson, E., Heller, J., Ryner, L., Karim, F., and Krasnow,
M. (2002). Developmental control of blood cell migration by the drosophila vegf
pathway. Cell, 108(6):865–876.
80
Christoforidis, S., McBride, H., Burgoyne, R., and Zerial, M. (1999a). The rab5
eﬀector eea1 is a core component of endosome docking. Nature, 397(6720):621–
625.
Christoforidis, S., Miaczynska, M., Ashman, K., Wilm, M., Zhao, L., Yip, S., Wa-
terfield, M., Backer, J., and Zerial, M. (1999b). Phosphatidylinositol-3-oh kinases
are rab5 eﬀectors. Nat Cell Biol, 1(4):249–252.
Conner, S. D. and Schmid, S. L. (2003). Regulated portals of entry into the cell.
Nature, 422(6927):37–44.
Daga, A., Karlovich, C., Dumstrei, K., and Banerjee, U. (1996). Patterning of cells
in the drosophila eye by lozenge, which shares homologous domains with aml1.
Genes & Development, 10(10):1194.
de Boer, J., Williams, A., Skavdis, G., Harker, N., Coles, M., Tolaini, M., Norton, T.,
Williams, K., Roderick, K., Potocnik, A. J., and Kioussis, D. (2003). Transgenic
mice with hematopoietic and lymphoid specific expression of cre. Eur J Immunol,
33(2):314–25.
Dietzl, G., Chen, D., Schnorrer, F., Su, K.-C., Barinova, Y., Fellner, M., Gasser, B.,
Kinsey, K., Oppel, S., Scheiblauer, S., Couto, A., Marra, V., Keleman, K., and
Dickson, B. J. (2007). A genome-wide transgenic rnai library for conditional gene
inactivation in drosophila. Nature, 448(7150):151–156.
Dimarcq, J. L., Imler, J. L., Lanot, R., Ezekowitz, R. A., Hoﬀmann, J. A., Janeway,
C. A., and Lagueux, M. (1997). Treatment of l(2)mbn drosophila tumorous blood
cells with the steroid hormone ecdysone amplifies the inducibility of antimicrobial
peptide gene expression. Insect Biochem Mol Biol, 27(10):877–86.
Dingli, D. and Pacheco, J. (2010). Modeling the architecture and dynamics of
hematopoiesis. WIREs Syst Biol Med, 2(2):235–244.
Dinneen, J. and Ceresa, B. (2004). Expression of dominant negative rab5 in hela cells
regulates endocytic traﬃcking distal from the plasma membrane. Experimental cell
research, 294(2):509–522.
Duvic, B., Hoﬀmann, J., Meister, M., and Royet, J. (2002). Notch signaling con-
trols lineage specification during drosophila larval hematopoiesis. Current Biology,
12(22):1923–1927.
Dzierzak, E. and Speck, N. A. (2008). Of lineage and legacy: the development of
mammalian hematopoietic stem cells. Nat Immunol, 9(2):129–136.
81
Elagib, K., Racke, F., Mogass, M., and Khetawat. . . , R. (2003). Runx1 and gata-1
coexpression and cooperation in megakaryocytic diﬀerentiation. Blood.
Evans, C., Hartenstein, V., and Banerjee, U. (2003). Thicker than blood:: Con-
served mechanisms in drosophila and vertebrate hematopoiesis. Developmental
cell, 5(5):673–690.
Evans, C., Sinenko, S., Mandal, L., Martinez-Agosto, J., Hartenstein, V., and Baner-
jee, U. (2007). Genetic dissection of hematopoiesis using drosophila as a model
system. Advances in Developmental Biology, 18:259–299.
Fessler, J., Kramerova, I., Kramerov, A., Chen, Y., and Fessler, L. (2004). Papilin, a
novel component of basement membranes, in relation to adamts metalloproteases
and ecm development. The International Journal of Biochemistry & Cell Biology,
36(6):1079–1084.
Fire, A., Xu, S., Montgomery, M., Kostas, S., Driver, S., and Mello, C. (1998).
Potent and specific genetic interference by double-stranded rna in caenorhabditis
elegans. Nature, 391(6669):806–811.
Formosa, T. (2008). Fact and the reorganized nucleosome. Mol. BioSyst.,
4(11):1085.
Fortini, M., Skupski, M., Boguski, M., and Hariharan, I. (2000). A survey of human
disease gene counterparts in the drosophila genome. The Journal of Cell Biology,
150(2):F23.
Fossett, N., Hyman, K., Gajewski, K., Orkin, S., and Schulz, R. (2003). Combi-
natorial interactions of serpent, lozenge, and u-shaped regulate crystal cell lin-
eage commitment during drosophila hematopoiesis. Proceedings of the National
Academy of Sciences of the United States of America, 100(20):11451.
Friedrich, G. and Soriano, P. (1991). Promoter traps in embryonic stem cells: a
genetic screen to identify and mutate developmental genes in mice. Genes Dev,
5(9):1513–1523.
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M.,
Nadaf, S., Kavanaugh, D., and Carbone, D. P. (1996). Production of vascular
endothelial growth factor by human tumors inhibits the functional maturation of
dendritic cells. Nature Medicine, 2(10):1096–103.
Gerber, H.-P. and Ferrara, N. (2003). The role of vegf in normal and neoplastic
hematopoiesis. J Mol Med, 81(1):20–31.
82
Gilliland, D. G., Jordan, C. T., and Felix, C. A. (2004). The molecular basis of
leukemia. Hematology Am Soc Hematol Educ Program, pages 80–97.
Gissen, P., Johnson, C., Gentle, D., Hurst, L., Doherty, A., O’Kane, C., Kelly, D.,
and Maher, E. (2005). Comparative evolutionary analysis of vps33 homologues:
genetic and functional insights. Human Molecular Genetics, 14(10):1261.
Godin, I. and Cumano, A. (2002). The hare and the tortoise: an embryonic
haematopoietic race. Nature Reviews Immunology, 2(8):593–604.
Goto, A., Kadowaki, T., and Kitagawa, Y. (2003). Drosophila hemolectin gene is
expressed in embryonic and larval hemocytes and its knock down causes bleeding
defects. Developmental Biology, 264(2):582–91.
Gould, G. and Lippincott-Schwartz, J. (2009). New roles for endosomes: from
vesicular carriers to multi-purpose platforms. Nat Rev Mol Cell Biol, 10(4):287–
292.
Haas, A. K., Fuchs, E., Kopajtich, R., and Barr, F. A. (2005). A gtpase-activating
protein controls rab5 function in endocytic traﬃcking. Nat Cell Biol, 7(9):887–893.
Hartenstein, V. (2006). Blood cells and blood cell development in the animal king-
dom. Annu. Rev. Cell Dev. Biol., 22:677–712.
Hattori, K., Dias, S., Heissig, B., Hackett, N. R., Lyden, D., Tateno, M., Hick-
lin, D. J., Zhu, Z., Witte, L., Crystal, R. G., Moore, M. A., and Rafii, S.
(2001). Vascular endothelial growth factor and angiopoietin-1 stimulate post-
natal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells.
J Exp Med, 193(9):1005–14.
Hedges, S., Blair, J., Venturi, M., and Shoe, J. (2004). A molecular timescale of
eukaryote evolution and the rise of complex multicellular life. BMC Evolutionary
Biology, 4(1):2.
Hertel, L., Andrea, M. D., Bellomo, G., Santoro, P., Landolfo, S., and Gariglio, M.
(1999). The hmg protein t160 colocalizes with dna replication foci and is down-
regulated during cell diﬀerentiation. Experimental cell research, 250(2):313–328.
Holz, A., Bossinger, B., Strasser, T., Janning, W., and Klapper, R. (2003). The two
origins of hemocytes in drosophila. Development, 130(20):4955.
Horiuchi, H., Lippé, R., McBride, H., Rubino, M., Woodman, P., Stenmark, H.,
Rybin, V., Wilm, M., Ashman, K., and Mann, M. (1997). A novel rab5 gdp/gtp
83
exchange factor complexed to rabaptin-5 links nucleotide exchange to eﬀector
recruitment and function. Cell, 90(6):1149–1159.
Hou, S., Zheng, Z., Chen, X., and Perrimon, N. (2002). The jak/stat pathway in
model organisms:: Emerging roles in cell movement. Developmental cell, 3(6):765–
778.
Huang, F., Khvorova, A., Marshall, W., and Sorkin, A. (2004). Analysis of clathrin-
mediated endocytosis of epidermal growth factor receptor by rna interference. Jour-
nal of Biological Chemistry, 279(16):16657.
Huizing, M., Didier, A., Walenta, J., Anikster, Y., Gahl, W., and Krämer, H. (2001).
Molecular cloning and characterization of human vps18, vps 11, vps16, and vps33.
Gene, 264(2):241–247.
Jiang, S.-Y. and Ramachandran, S. (2006). Comparative and evolutionary analysis of
genes encoding small gtpases and their activating proteins in eukaryotic genomes.
Physiological Genomics, 24(3):235–51.
Jimeno-Gonzalez, S., Gomez-Herreros, F., Alepuz, P. M., and Chavez, S. (2006).
A gene-specific requirement for fact during transcription is related to the chro-
matin organization of the transcribed region. Molecular and Cellular Biology,
26(23):8710–8721.
Kavanagh, E., Buchert, M., Tsapara, A., Choquet, A., Balda, M. S., Hollande,
F., and Matter, K. (2006). Functional interaction between the zo-1-interacting
transcription factor zonab/dbpa and the rna processing factor symplekin. Journal
of Cell Science, 119(24):5098–5105.
Keller, D. and Lu, H. (2002). p53 serine 392 phosphorylation increases after uv
through induction of the assembly of the ck2Â· hspt16Â· ssrp1 complex. Journal
of Biological Chemistry, 277(51):50206.
Keller, D., Zeng, X., Wang, Y., Zhang, Q., Kapoor, M., Shu, H., Goodman, R.,
Lozano, G., Zhao, Y., and Lu, H. (2001). A dna damage-induced p53 serine 392
kinase complex contains ck2, hspt16, and ssrp1. Molecular Cell, 7(2):283–292.
Kennerdell, J. and Carthew, R. (2000). Heritable gene silencing in drosophila using
double-stranded rna. Nature Biotechnology, 18(8):896–898.
Keon, B., Schäfer, S., Kuhn, C., Grund, C., and Franke, W. (1996). Symplekin,
a novel type of tight junction plaque protein. The Journal of cell biology,
134(4):1003–1018.
84
Kim, B., Krämer, H., Yamamoto, A., Kominami, E., Kohsaka, S., and Akazawa, C.
(2001). Molecular characterization of mammalian homologues of class c vps pro-
teins that interact with syntaxin-7. Journal of Biological Chemistry, 276(31):29393.
Kolev, N. and Steitz, J. (2005). Symplekin and multiple other polyadenylation fac-
tors participate in 3’-end maturation of histone mrnas. Genes & Development,
19(21):2583.
Kondo, M., Wagers, A. J., Manz, M. G., Prohaska, S. S., Scherer, D. C., Beilhack,
G. F., Shizuru, J. A., and Weissman, I. L. (2003). Biology of hematopoietic stem
cells and progenitors: implications for clinical application. Annu. Rev. Immunol.,
21:759–806.
Kramerova, I., Kawaguchi, N., Fessler, L., Nelson, R., Chen, Y., Kramerov, A.,
Kusche-Gullberg, M., Kramer, J., Ackley, B., and Sieron, A. (2000). Papilin in
development; a pericellular protein with a homology to the adamts metallopro-
teinases. Development, 127(24):5475.
Kramerova, I. A., Kramerov, A. A., and Fessler, J. H. (2003). Alternative splicing
of papilin and the diversity of drosophila extracellular matrix during embryonic
morphogenesis. Dev. Dyn., 226(4):634–642.
Krzemien, J., Oyallon, J., Crozatier, M., and Vincent, A. (2010). Hematopoietic
progenitors and hemocyte lineages in the drosophila lymph gland. Developmental
Biology, 346(2):310–319.
Kumano, K., Chiba, S., Kunisato, A., Sata, M., Saito, T., Nakagami-Yamaguchi, E.,
Yamaguchi, T., Masuda, S., Shimizu, K., Takahashi, T., Ogawa, S., Hamada, Y.,
and Hirai, H. (2003). Notch1 but not notch2 is essential for generating hematopoi-
etic stem cells from endothelial cells. Immunity, 18(5):699–711.
Kumano, K., Chiba, S., Shimizu, K., Yamagata, T., Hosoya, N., Saito, T., Taka-
hashi, T., Hamada, Y., and Hirai, H. (2001). Notch1 inhibits diﬀerentiation of
hematopoietic cells by sustaining gata-2 expression. Blood, 98(12):3283–9.
Kumari, S., Mg, S., and Mayor, S. (2010). Endocytosis unplugged: multiple ways to
enter the cell. Cell Research, (3):256–275.
Lanot, R., Zachary, D., Holder, F., and Meister, M. (2001). Postembryonic
hematopoiesis in drosophila. Developmental Biology, 230(2):243–257.
Lebestky, T., Jung, S., and Banerjee, U. (2003). A serrate-expressing signaling center
controls drosophila hematopoiesis. Genes & Development, 17(3):348.
85
Lemaitre, B. and Hoﬀmann, J. (2007). The host defense of drosophila melanogaster.
Annu. Rev. Immunol., 25(1):697–743.
Li, G. and Stahl, P. (1993). Structure-function relationship of the small gtpase rab5.
Journal of Biological Chemistry, 268(32):24475.
Li, Y., Zeng, S. X., Landais, I., and Lu, H. (2007). Human ssrp1 has spt16-dependent
and -independent roles in gene transcription. J Biol Chem, 282(10):6936–45.
Lindsell, C. E., Shawber, C. J., Boulter, J., and Weinmaster, G. (1995). Jagged: a
mammalian ligand that activates notch1. Cell, 80(6):909–17.
Lopez-Bigas, N., De, S., and Teichmann, S. A. (2008). Functional protein divergence
in the evolution of homo sapiens. Genome Biol, 9(2):R33.
Lutz, C. S. (2008). Alternative polyadenylation: a twist on mrna 3’ end formation.
ACS Chem Biol, 3(10):609–17.
Medvinsky, A., Rybtsov, S., and Taoudi, S. (2011). Embryonic origin of the adult
hematopoietic system: advances and questions. Development, 138(6):1017–31.
Meister, M. (2004). Blood cells of drosophila: cell lineages and role in host defence.
Current opinion in immunology, 16(1):10–15.
Mercher, T., Raﬀel, G. D., Moore, S. A., Cornejo, M. G., Baudry-Bluteau, D.,
Cagnard, N., Jesneck, J. L., Pikman, Y., Cullen, D., Williams, I. R., Akashi, K.,
Shigematsu, H., Bourquin, J.-P., Giovannini, M., Vainchenker, W., Levine, R. L.,
Lee, B. H., Bernard, O. A., and Gilliland, D. G. (2009). The ott-mal fusion
oncogene activates rbpj-mediated transcription and induces acute megakaryoblas-
tic leukemia in a knockin mouse model. Journal of Clinical Investigation, pages
1–13.
Minakhina, S. and Steward, R. (2010). Hematopoietic stem cells in drosophila.
Development, 137(1):27–31.
Nakamura, N., Hirata, A., Ohsumi, Y., and Wada, Y. (1997). Vam2/vps41p and
vam6/vps39p are components of a protein complex on the vacuolar membranes
and involved in the vacuolar assembly in the yeast saccharomyces cerevisiae. J
Biol Chem, 272(17):11344–9.
Nakamura, N., Yamamoto, A., Wada, Y., and Futai, M. (2000). Syntaxin 7 me-
diates endocytic traﬃcking to late endosomes. Journal of Biological Chemistry,
275(9):6523.
86
Neely, G. G., Hess, A., Costigan, M., Keene, A. C., Goulas, S., Langeslag, M.,
Griﬃn, R. S., Belfer, I., Dai, F., Smith, S. B., Diatchenko, L., Gupta, V., ping
Xia, C., Amann, S., Kreitz, S., Heindl-Erdmann, C., Wolz, S., Ly, C. V., Arora, S.,
Sarangi, R., Dan, D., Novatchkova, M., Rosenzweig, M., Gibson, D. G., Truong,
D., Schramek, D., Zoranovic, T., Cronin, S. J. F., Angjeli, B., Brune, K., Dietzl,
G., Maixner, W., Meixner, A., Thomas, W., Pospisilik, J. A., Alenius, M., Kress,
M., Subramaniam, S., Garrity, P. A., Bellen, H. J., Woolf, C. J., and Penninger,
J. M. (2010a). A genome-wide drosophila screen for heat nociception identifies
&alpha;2&delta;3 as an evolutionarily conserved pain gene. Cell, 143(4):628–638.
Neely, G. G., Kuba, K., Cammarato, A., Isobe, K., Amann, S., Zhang, L., Murata,
M., Elmen, L., Gupta, V., Arora, S., Sarangi, R., Dan, D., Fujisawa, S., Usami, T.,
ping Xia, C., Keene, A. C., Alayari, N. N., Yamakawa, H., Elling, U., Berger, C.,
Novatchkova, M., Koglgruber, R., Fukuda, K., Nishina, H., Isobe, M., Pospisilik,
J. A., Imai, Y., Pfeufer, A., Hicks, A. A., Pramstaller, P. P., Subramaniam, S.,
Kimura, A., Ocorr, K., Bodmer, R., and Penninger, J. M. (2010b). A global in vivo
drosophila rnai screen identifies not3 as a conserved regulator of heart function.
Cell, 141(1):142–153.
Nielsen, E., Christoforidis, S., Uttenweiler-Joseph, S., Miaczynska, M., Dewitte, F.,
Wilm, M., Hoflack, B., and Zerial, M. (2000). Rabenosyn-5, a novel rab5 eﬀector,
is complexed with hvps45 and recruited to endosomes through a fyve finger domain.
The Journal of cell biology, 151(3):601.
Novak, A., Guo, C., Yang, W., Nagy, A., and Lobe, C. (2000). Z/eg, a double
reporter mouse line that expresses enhanced green fluorescent protein upon cre-
mediated excision. genesis, 28(3-4):147–155.
Ono, R., Nakajima, H., Ozaki, K., Kumagai, H., Kawashima, T., Taki, T., Kitamura,
T., Hayashi, Y., and Nosaka, T. (2005). Dimerization of mll fusion proteins and
flt3 activation synergize to induce multiple-lineage leukemogenesis. Journal of
Clinical Investigation, 115(4):919–929.
Orphanides, G., Wu, W., Lane, W., Hampsey, M., and Reinberg, D. (1999). The
chromatin-specific transcription elongation factor fact comprises human spt16 and
ssrp1 proteins. Nature, 400(6741):284–288.
Palacios, R. and Steinmetz, M. (1985). Il3-dependent mouse clones that express
b-220 surface antigen, contain ig genes in germ-line configuration, and generate b
lymphocytes in vivo. Cell, 41(3):727–734.
87
Peplowska, K., Markgraf, D. F., Ostrowicz, C. W., Bange, G., and Ungermann, C.
(2007). The corvet tethering complex interacts with the yeast rab5 homolog vps21
and is involved in endo-lysosomal biogenesis. Developmental cell, 12(5):739–50.
Pospisilik, J. A., Schramek, D., Schnidar, H., Cronin, S. J. F., Nehme, N. T., Zhang,
X., Knauf, C., Cani, P. D., Aumayr, K., Todoric, J., Bayer, M., Haschemi, A.,
Puviindran, V., Tar, K., Orthofer, M., Neely, G. G., Dietzl, G., Manoukian, A.,
Funovics, M., Prager, G., Wagner, O., Ferrandon, D., Aberger, F., chung Hui,
C., Esterbauer, H., and Penninger, J. M. (2010). Drosophila genome-wide obesity
screen reveals hedgehog as a determinant of brown versus white adipose cell fate.
Cell, 140(1):148–160.
Prekeris, R., Yang, B., Oorschot, V., Klumperman, J., and Scheller, R. (1999).
Diﬀerential roles of syntaxin 7 and syntaxin 8 in endosomal traﬃcking. Molecular
Biology of the Cell, 10(11):3891.
Pryor, P. R., Mullock, B. M., Bright, N. A., Lindsay, M. R., Gray, S. R., Richardson,
S. C. W., Stewart, A., James, D. E., Piper, R. C., and Luzio, J. P. (2004).
Combinatorial snare complexes with vamp7 or vamp8 define diﬀerent late endocytic
fusion events. EMBO Rep, 5(6):590–595.
Qiu, P., Pan, P., and Govind, S. (1998). A role for the drosophila toll/cactus pathway
in larval hematopoiesis. Development, 125(10):1909.
Rehorn, K., Thelen, H., Michelson, A., and Reuter, R. (1996). A molecular aspect of
hematopoiesis and endoderm development common to vertebrates and drosophila.
Development, 122(12):4023.
Renneville, A., Roumier, C., Biggio, V., and Nibourel. . . , O. (2008). Cooperating
gene mutations in acute myeloid leukemia: a review of the literature. Leukemia.
Reumer, A., Loy, T. V., and Schoofs, L. (2010). The complexity of drosophila innate
immunity. ISJ, 7:32–44.
Richardson, S., Winistorfer, S., Poupon, V., Luzio, J., and Piper, R. (2004). Mam-
malian late vacuole protein sorting orthologues participate in early endosomal fusion
and interact with the cytoskeleton. Molecular Biology of the Cell, 15(3):1197.
Rink, J., Ghigo, E., Kalaidzidis, Y., and Zerial, M. (2005). Rab conversion as a
mechanism of progression from early to late endosomes. Cell, 122(5):735–749.
88
Rizki, T., Rizki, R., and Grell, E. (1980). A mutant aﬀecting the crystal cells in
drosophila melanogaster. Wilhelm Roux’s Archives of Developmental Biology,
188(2):91–99.
Rubin, G., Yandell, M., Wortman, J., Miklos, G. G., Nelson, C., Hariharan, I., Fortini,
M., Li, P., Apweiler, R., and Fleischmann, W. (2000). Comparative genomics of
the eukaryotes. Science, 287(5461):2204.
Schindler, J. W., Buren, D. V., Foudi, A., Krejci, O., Qin, J., Orkin, S. H., and
Hock, H. (2009). Tel-aml1 corrupts hematopoietic stem cells to persist in the
bone marrow and initiate leukemia. Stem Cell, 5(1):43–53.
Sevrioukov, E. A., He, J. P., Moghrabi, N., Sunio, A., and Krämer, H. (1999). A
role for the deep orange and carnation eye color genes in lysosomal delivery in
drosophila. Molecular Cell, 4(4):479–86.
Shirakata, M., Hüppi, K., Usuda, S., Okazaki, K., Yoshida, K., and Sakano, H.
(1991). Hmg1-related dna-binding protein isolated with v-(d)-j recombination sig-
nal probes. Mol Cell Biol, 11(9):4528–36.
Shrestha, R. and Gateﬀ, E. (1982). Ultrastructure and cytochemistry of the cell types
in the larval hematopoietic organs and hemolymph of drosophila melanogaster.
Development, Growth & Diﬀerentiation, 24(1):65–82.
Silverman, N. and Maniatis, T. (2001). Nf-Îºb signaling pathways in mammalian and
insect innate immunity. Genes & Development, 15(18):2321.
Simonsen, A., Lippe, R., Christoforidis, S., Gaullier, J., Brech, A., Callaghan, J.,
Toh, B., Murphy, C., Zerial, M., and Stenmark, H. (1998). Eea1 links pi (3) k
function to rab5 regulation of endosome fusion. Nature, 394(6692):494–498.
Sorkin, A. and Zastrow, M. V. (2009). Endocytosis and signalling: intertwining
molecular networks. Nat Rev Mol Cell Biol, 10(9):609–622.
Spencer, J., Baron, M., and Olson, E. (1999). Cooperative transcriptional activation
by serum response factor and the high mobility group protein ssrp1. Journal of
Biological Chemistry, 274(22):15686.
Stenmark, H. (2009). Rab gtpases as coordinators of vesicle traﬃc. Nat Rev Mol
Cell Biol, 10(8):513–25.
89
Stenmark, H., Parton, R., Steele-Mortimer, O., Lütcke, A., Gruenberg, J., and Ze-
rial, M. (1994). Inhibition of rab5 gtpase activity stimulates membrane fusion in
endocytosis. The EMBO Journal, 13(6):1287.
Strömberg, S., Agnarsdóttir, M., Magnusson, K., Rexhepaj, E., Bolander, Å., Lund-
berg, E., Asplund, A., Ryan, D., Raﬀerty, M., and Gallagher, W. (2009). Selective
expression of syntaxin-7 protein in benign melanocytes and malignant melanoma.
Journal of proteome research, 8(4):1639–1646.
Suzuki, T., Oiso, N., Gautam, R., Novak, E., Panthier, J., Suprabha, P., Vida, T.,
Swank, R., and Spritz, R. (2003). The mouse organellar biogenesis mutant buﬀ
results from a mutation in vps33a, a homologue of yeast vps33 and drosophila
carnation. Proceedings of the National Academy of Sciences of the United States
of America, 100(3):1146.
Takagaki, Y. and Manley, J. (2000). Complex protein interactions within the human
polyadenylation machinery identify a novel component. Molecular and cellular
biology, 20(5):1515.
Tan, B. C.-M., Chien, C.-T., Hirose, S., and Lee, S.-C. (2006). Functional co-
operation between fact and mcm helicase facilitates initiation of chromatin dna
replication. EMBO J, 25(17):3975–3985.
Tavian, M., Biasch, K., Sinka, L., Vallet, J., and Péault, B. (2010). Embryonic origin
of human hematopoiesis. Int. J. Dev. Biol, 54:1061–1065.
Teng, F., Wang, Y., and Tang, B. (2001). The syntaxins. Genome Biol, 2(11).
Tepass, U., Fessler, L., Aziz, A., and Hartenstein, V. (1994). Embryonic origin
of hemocytes and their relationship to cell death in drosophila. Development,
120(7):1829.
Toney, J., Donahue, B., Kellett, P., Bruhn, S., Essigmann, J., and Lippard, S.
(1989). Isolation of cdnas encoding a human protein that binds selectively to dna
modified by the anticancer drug cis-diamminedichloroplatinum (ii). Proceedings of
the National Academy of Sciences of the United States of America, 86(21):8328.
Tsang, A., Visvader, J., Turner, C., and Fujiwara. . . , Y. (1997). Fog, a multitype
zinc finger protein, acts as a cofactor for transcription factor gata-1 in erythroid
and megakaryocytic diﬀerentiation. Cell.
90
Ullrich, O., Horiuchi, H., Bucci, C., and Zerial, M. (1994). Membrane association
of rab5 mediated by gdp-dissociation inhibitor and accompanied by gdp/gtp ex-
change.
Waltzer, L., Bataillé, L., Peyrefitte, S., and Haenlin, M. (2002). Two isoforms
of serpent containing either one or two gata zinc fingers have diﬀerent roles in
drosophila haematopoiesis. EMBO J, 21(20):5477–5486.
Waltzer, L., Gobert, V., Osman, D., and Haenlin, M. (2010). Transcription factor
interplay during drosophila haematopoiesis. Int. J. Dev. Biol., 54(6-7):1107–1115.
Williams, M. (2007). Drosophila hemopoiesis and cellular immunity. The journal of
immunology, 178(8):4711.
Wong, E. T. and Tergaonkar, V. (2009). Roles of nf-kappab in health and disease:
mechanisms and therapeutic potential. Clin Sci, 116(6):451–65.
Wong, S., Xu, Y., Zhang, T., and Hong, W. (1998). Syntaxin 7, a novel syntaxin
member associated with the early endosomal compartment. Journal of Biological
Chemistry, 273(1):375.
Wood, W. and Jacinto, A. (2007). Drosophila melanogaster embryonic haemocytes:
masters of multitasking. Nat Rev Mol Cell Biol, 8(7):542–551.
Wu, C., Orozco, C., Boyer, J., Leglise, M., Goodale, J., Batalov, S., Hodge, C. L.,
Haase, J., Janes, J., Huss, J. W., and Su, A. I. (2009). Biogps: an extensible
and customizable portal for querying and organizing gene annotation resources.
Genome Biol, 10(11):R130.
Xing, H., Mayhew, C., Cullen, K., Park-Sarge, O., and Sarge, K. (2004). Hsf1
modulation of hsp70 mrna polyadenylation via interaction with symplekin. Journal
of Biological Chemistry, 279(11):10551.
Yuan, Y., Zhou, L., Miyamoto, T., Iwasaki, H., Harakawa, N., Hetherington, C.,
Burel, S., Lagasse, E., Weissman, I., and Akashi, K. (2001). Aml1-eto expression
is directly involved in the development of acute myeloid leukemia in the presence
of additional mutations. Proceedings of the National Academy of Sciences of the
United States of America, 98(18):10398.
Zastrow, M. V. and Sorkin, A. (2007). Signaling on the endocytic pathway. Current
opinion in cell biology, 19(4):436–45.
91
Zeng, S. X., Dai, M.-S., Keller, D. M., and Lu, H. (2002a). Ssrp1 functions as a
co-activator of the transcriptional activator p63. EMBO J, 21(20):5487–97.
Zeng, Y., Wagner, E. J., and Cullen, B. R. (2002b). Both natural and designed micro
rnas can inhibit the expression of cognate mrnas when expressed in human cells.
Mol Cell, 9(6):1327–33.
Zuber, J., Radtke, I., Pardee, T. S., Zhao, Z., Rappaport, A. R., Luo, W., Mccurrach,
M. E., Yang, M.-M., Dolan, M. E., Kogan, S. C., Downing, J. R., and Lowe, S. W.
(2009). Mouse models of human aml accurately predict chemotherapy response.
Genes & Development, 23(7):877–889.
92
Curriculum Vitae
Personal Information
Name Marie-Theres Tazreiter
Address Marktgasse 8-10/1/12
A-1090 Vienna
Phone (+43) 650 42 1 42 66
e-mail marie.tazreiter@gmail.com
Nationality Austria
Date of Birth 31/03/1987
Place of Birth Klagenfurt, Austria
Education
October 2005 - April 2011 Study of Molecular Biology (Master Degree)
University of Vienna, Austria
June 2005 High-school graduation (passed with honors)
1997 - 2005 High School
BG/BRG St. Martin, Villach, Austria
1993 - 1997 Primary School
Hermagor and Villach, Austria
93
Research experience
Oct 2010 - March 2011 Technical Assistant
Prof. Dr. Josef Penninger
IMBA – Institute of Molecular Biotechnology
GmbH Austrian Academy of Science
Vienna, Austria
Oct 2009 - Sep 2010 Diploma Thesis
Prof. Dr. Josef Penninger
IMBA – Institute of Molecular Biotechnology
GmbH Austrian Academy of Science
Vienna, Austria
March 2009 - June 2009 Internship
“The role of PTEN, CK2 and the PI3K/Akt
pathway in B cell acute lymphoblastic
leukemia”
Cancer Biology Unit - João Taborda Barata
Instituto de Medicina Molecular
Lisbon, Portugal
Oct 2008 - Feb 2009 Internship
“The Role of RANK in the Development and
Maintenance of Central Tolerance”
Prof. Dr. Josef Penninger
IMBA – Institute of Molecular Biotechnology
GmbH Austrian Academy of Science
Vienna, Austria
July and August 2008 Internship
“The γ-Secretase and Alzheimer Disease -
Towards Elucidation of the Protein Structure”
Bing K. Jap
Lawrence Berkeley National Laboratories
Berkeley, California, USA
94
